Search:
Tokushima University > Graduate School of Biomedical Sciences > 医学域 > Medical Science > Internal Medicine > Department of hematology, endocrinology and metabolism >
Tokushima University > Research Clusters > Research Clusters (Registered) > 1804024 HTLV-1ウイルスの感染伝播抑制と難治性腫瘍成人T細胞白血病/リンパ腫に対する新規治療法の開発 >
Tokushima University > Research Clusters > Research Clusters (Prioritized) > 1802003 がんの統合的診断・治療を目指した分子から組織のマルチスケール・バイブレーショナル光学顕微鏡の創成 >
Tokushima University > University Hospital > Clinical Division > Department of Internal Medicine > Hematology >
Tokushima University > Research Clusters > Research Clusters (Registered) > 1704034 高齢化社会に対応する「虚弱」の評価・治療モダリティーの創出 >
Tokushima University > Research Clusters > Research Clusters (Registered) > 1704025 個別化医療の実現に向けた,医薬品による副作用発現予測遺伝子マーカーの同定 >
Tokushima University > Faculty of Medicine > School of Medicine > Course of Molecular Medicine > Hemotology, endocrinology and metabolism >
Tokushima University > Graduate School of Medical Sciences > Medical Science > Molecular Medicine >
Tokushima University > Research Clusters > Research Clusters (Selected) > 1803003 リード薬の構造展開による新規阻害薬の創出とその物性・治療活性の最適化 >
(CSV files for researchmap) [PDF manual]

Research Activity

Field of Study

Medicine
Hematology, Oncology

Subject of Study

biology and treatment of hematological tumors (myeloma, immunotherapy, hematopoietsis, hematological malignancy)

Book / Paper

Book:

1. Sumiko Yoshida, 原 倫世, 山口 佑樹, Takeshi Kondo, 遠藤 ふうり, 筒井 康継, 桝田 志保, Kiyoe Kurahashi, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe, Kohhei Nakajima and Masahiro Abe :
急速に腫瘍が増大し悪性転化が疑われたCushing病の1例,
Jun. 2019.
2. Jumpei Teramachi and Masahiro Abe :
TAK-1を標的とした骨髄腫骨破壊病変治療薬開発,
NIPPONRINSHOSHA Co.,Ltd., Jul. 2016.
3. Masahiro Abe :
「臨床血液学—最新情報と今後の展望 2016年版」 多発性骨髄腫,
臨床血液, Feb. 2016.
4. Masahiro Abe, 三木 浩和 and 中村 信元 :
臨床血液学—最新情報と今後の展望 2016年版,
臨床血液, 2016.
5. Masahiro Abe :
もっと知って欲しい多発性骨髄腫のこと 2015年版,
監修 キャンサーネットジャパン制作, Nov. 2015.
6. Masahiro Abe :
多発性骨髄腫における骨病変の発症機構.ブラッシュアップ多発性骨髄腫,
中外医学社, Oct. 2015.
7. Masahiro Abe :
多発性骨髄腫.Principle and Practice 血液・造血器・リンパ系,
千葉滋集, Oct. 2015.
8. Masahiro Abe :
話題 多発性骨髄腫のPim-2キナーゼの意義,
化学評論社, Aug. 2015.
9. Masahiro Abe :
多発性骨髄腫.骨ペディア 骨疾患・骨代謝キーワード辞典,
羊土社, May 2015.
10. Masahiro Abe :
多発性骨髄腫,
羊土社, May 2015.
11. Masahiro Abe :
今日の治療指針 2015年版-私はこう治療している,
医学書院, Jan. 2015.
12. Masahiro Abe :
「骨髄腫∼いつ治療するのか?∼初発,再発,そして早期介入」骨髄腫骨病変の管理:ゾレドロン酸かデノスマブか,
臨床血液, 2015.
13. Masahiro Abe :
骨髄腫の骨病変:分子機序,
Parma Medica, 2015.
14. Shingen Nakamura and Masahiro Abe :
臓器移植.ALアミロイドーシス,多発性骨髄腫の類縁疾患,
Iyaku Journal Co., Ltd., Aug. 2014.
15. Shingen Nakamura and Masahiro Abe :
アミロイドーシス効果判定基準 効果判定基準 2005コンセンサスクライテリア,2011新基準.ALアミロイドーシス,多発性骨髄腫の類縁疾患,
Iyaku Journal Co., Ltd., Aug. 2014.
16. Hirokazu Miki and Masahiro Abe :
アミロイド原性light chainの脾臓での産生 ALアミロイドーシス,多発性骨髄腫の類縁疾患,
Iyaku Journal Co., Ltd., Aug. 2014.
17. Masahiro Abe :
骨粗鬆症の類縁疾患とその治療,
Iyaku Journal Co., Ltd., Oct. 2013.
18. Masahiro Abe :
骨転移の骨病変形成のメカニズム 多発性骨髄腫,
Medical Review Co.,Ltd, Oct. 2013.
19. Masahiro Abe :
骨転移の増殖・進展のメカニズム 多発性骨髄腫,
Medical Review Co.,Ltd, Oct. 2013.
20. Masahiro Abe :
骨髄腫に伴う骨病変の発症機序,
Medical Review Co.,Ltd, Sep. 2013.
21. Masahiro Abe :
骨痛に対する対策,ビスホスホネートとデノスマブの使い分け,
Iyaku Journal Co., Ltd., Jul. 2013.
22. Masahiro Abe and Itsuro Endo :
高カルシウム血症,
Iyaku Journal Co., Ltd., Mar. 2013.
23. Masahiro Abe :
骨病変に対する新規治療薬の開発動向,
Iyaku Journal Co., Ltd., Mar. 2013.
24. Masahiro Abe :
骨病変のマネージメント,
Iyaku Journal Co., Ltd., Mar. 2013.
25. Masahiro Abe :
骨代謝マーカーの使い方,
Iyaku Journal Co., Ltd., Mar. 2013.
26. Masahiro Abe :
骨病変 1) 病態,症状 多発性骨髄腫の症候/合併症とその対策,
Iyaku Journal Co., Ltd., Mar. 2013.
27. Itsuro Endo, Masahiro Abe and Toshio Matsumoto :
骨転移の分子標的治療薬,
Dec. 2012.
28. Masahiro Abe :
多発性骨髄腫の骨病変,
Dec. 2012.
29. Hirokazu Miki and Masahiro Abe :
多発性骨髄腫に対する合併症の治療(腎,骨,感染症),
Oct. 2012.
30. Masahiro Abe :
M蛋白がもたらす注意すべき病態,検査値異常,
Oct. 2012.
31. Masahiro Abe :
骨病変の評価(3)バイオマーカー,
Oct. 2012.
32. Masahiro Abe :
骨代謝マーカー:検査値の見方と評価,
Oct. 2012.
33. Masahiro Abe :
骨病変,
Oct. 2012.
34. Kumiko Kagawa, Masahiro Abe and Toshio Matsumoto :
がん骨転移治療―ビスフォスフォネート治療によるBone Management,
SENTAN IGAKU-SHA, Mar. 2012.
35. Shingen Nakamura, Masahiro Abe and Toshio Matsumoto :
新規治療薬の開発と臨床応用の可能性を探る (抗RANKL抗体などを中心に),
Mar. 2012.
36. Masahiro Abe :
多発性骨髄腫における骨破壊機構とその治療,
中外医学社, Oct. 2011.
37. Masahiro Abe :
高カルシウム血症,
医薬ジャーナル社, Feb. 2011.
38. 三木 浩和 and Masahiro Abe :
Oncology Emergency 過粘稠症候群,
メディカルビュー社, 2011.
39. Masahiro Abe and Toshio Matsumoto :
第2章 サイトカインによる生体調節機構 3)代謝,
YODOSHA CO., LTD., Tokyo, Nov. 2005.
40. Masahiro Abe and Toshio Matsumoto :
A mechanism of bone destruction in multiple myeloma,
Medical Review Co.,Ltd, Osaka, Nov. 2005.
41. Masahiro Abe and Toshio Matsumoto :
Bone Marrow in Cancer Metastasis,
Shujunsha Co.Ltd., Tokyo, Jul. 2005.
42. Masahiro Abe :
骨髄腫細胞は形質細胞とどこが違うのか?,
SENTAN IGAKU-SHA, Tokyo, 2005.
43. Masahiro Abe and Toshio Matsumoto :
癌と骨組織との相互作用,
Nakayama-Shoten Co., Ltd., Tokyo, Oct. 2004.
44. Toshihiro Hashimoto, Masahiro Abe and Toshio Matsumoto :
[Biochemical markers in bone metastasis].,
癌と化学療法社, Tokyo, Jul. 2004.
(PubMed: 15272580,   Elsevier: Scopus)
45. Toshihiro Hashimoto, Masahiro Abe and Toshio Matsumoto :
癌に伴う骨病変の病態と治療,
Nankodo, Tokyo, Apr. 2004.
46. Masahiro Abe and 大島 隆志 :
骨髄腫細胞と骨芽細胞,
科学評論社, Tokyo, Mar. 2004.
47. Toshihiro Hashimoto, Masahiro Abe and Daisuke Inoue :
骨髄腫のビスフォスフォネート療法,
KANEHARA & CO., LTD., Tokyo, Jan. 2003.
48. Masahiro Abe :
骨病変に対するbisphosphonateの有効性,
科学評論社, Tokyo, Nov. 2002.
49. 若槻 真吾, Masahiro Abe and 小阪 昌明 :
Ⅳ.検査の実際 6.多発性骨髄腫と関連疾患,
IGAKU-SHOIN Ltd.Tokyo,Japan, Tokyo, Oct. 2002.
50. Masahiro Abe, 大島 隆志 and 小阪 昌明 :
Ⅳ.検査の実際 6.多発性骨髄腫と関連疾患,
IGAKU-SHOIN Ltd.Tokyo,Japan, Tokyo, Oct. 2002.

Academic Paper (Judged Full Paper):

1. Yuichi Takashi, Hidetaka Kosako, Shun Sawatsubashi, Yuka Kinoshita, Nobuaki Ito, Maria K. Tsoumpra, Masaomi Nangaku, Masahiro Abe, Munehide Matsuhisa, Shigeaki Kato, Toshio Matsumoto and Seiji Fukumoto :
Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation,
Proceedings of the National Academy of Sciences of the United States of America, Vol.116, No.23, 11418-11427, 2019.
(Tokushima University Institutional Repository: 113621,   DOI: 10.1073/pnas.1815166116,   PubMed: 31097591)
2. Dong Bingzi, Itsuro Endo, Ohnishi Yukoyo, Mitsui Yukari, Kiyoe Kurahashi, Mai Kanai, Masahiro Hiasa, Jumpei Teramachi, Hirofumi Tenshin, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
Persistent Activation of Calcium-Sensing Receptor Suppresses Bone Turnover, Increases Microcracks, and Decreases Bone Strength.,
JBMR Plus, Vol.3, No.7, e10182, 2019.
(DOI: 10.1002/jbm4.10182,   PubMed: 31372589)
3. Yuko Miyakami, Shingen Nakamura, Masahiro Oura, Yasunobu Okamoto, 高橋 真美子, Kimiko Sogabe, 岩佐 昌美, Takeshi Harada, Shiroh Fujii, Hirokazu Miki, Kumiko Kagawa, Hisanori Uehara and Masahiro Abe :
不明熱と著明な高CRP血症で発症したde novo CD20陰性びまん性大細胞型B細胞リンパ腫の1例,
Shikoku Acta Medica, Vol.74, No.5-6, 193-200, 2018.
(Tokushima University Institutional Repository: 112987)
4. Seiji Kishi, 小幡 史明, Hirokazu Miki, Motokazu Matsuura, Masanori Tamaki, Fumi Kishi, 西村 賢二, Taichi Murakami, Hideharu Abe, Kojiro Nagai, Masahiro Abe and Toshio Doi :
A case of Lambda Light Chain Noncrystalline Proximal Tubulopathy with IgD lambda myeloma,
Internal Medicine, 2018.
(DOI: 10.2169/internalmedicine.1323-18,   PubMed: 30101939)
5. Kumiko Kagawa, Hikaru Fujino, Hirokazu Miki, Kimiko Sogabe, Mamiko Takahashi, Tomoko Maruhashi, Kengo Udaka, Masami Iwasa, Shiro Fujii, Shingen Nakamura and Masahiro Abe :
Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: Detection of Cryptosporidium oocysts by intestinal biopsies.,
Transplant Infectious Disease, Vol.20, No.2, e12826, 2018.
(DOI: 10.1111/tid.12826,   PubMed: 29277954,   Elsevier: Scopus)
6. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Takeshi Harada, Shingen Nakamura, Ryota Amachi, Hirofumi Tenshin, Masami Iwasa, Shiroh Fujii, Kumiko Kagawa, Hirokazu Miki, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.,
British Journal of Haematology, Vol.180, No.4, 581-585, 2018.
(Tokushima University Institutional Repository: 112935,   DOI: 10.1111/bjh.14388,   PubMed: 27748523)
7. Hirokazu Miki, Shingen Nakamura, Asuka Oda, Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Ariunzaya Bat-Erdene, Yusaku Maeda, Masahiro Oura, Mamiko Takahashi, Masami Iwasa, Takeshi Harada, Shiroh Fujii, Kiyoe Kurahashi, Sumiko Yoshida, Kumiko Kagawa, Itsuro Endo, Aihara Kenichi, Mariko Ikuo, Kouji Itou, Koichiro Hayashi, Michihiro Nakamura and Masahiro Abe :
Effective impairment of myeloma cells and their progenitors by hyperthermia.,
Oncotarget, Vol.9, No.12, 10307-10316, 2017.
(Tokushima University Institutional Repository: 113059,   DOI: 10.18632/oncotarget.23121,   PubMed: 29535808,   Elsevier: Scopus)
8. Hirofumi Tenshin, Jumpei Teramachi, Asuka Oda, Ryota Amachi, Masahiro Hiasa, Ariunzaya Bat-Erdene, Keiichiro Watanabe, Masami Iwasa, Takeshi Harada, Shiroh Fujii, Kumiko Kagawa, Kimiko Sogabe, Shingen Nakamura, Hirokazu Miki, Kiyoe Kurahashi, Sumiko Yoshida, Kenichi Aihara, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects.,
Blood Advances, Vol.1, No.24, 2124-2137, 2017.
(Tokushima University Institutional Repository: 113517,   DOI: 10.1182/bloodadvances.2017008813,   PubMed: 29296860)
9. Kiyoe Kurahashi, Itsuro Endo, Takeshi Kondo, Kana Morimoto, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Kohhei Nakajima, Yoshifumi Mizobuchi, Shinji Nagahiro, Masahiro Abe and Seiji Fukumoto :
Remarkable Shrinkage of a Growth Hormone (GH)-secreting Macroadenoma Induced by Somatostatin Analogue Administration: A Case Report and Literature Review.,
Internal Medicine, Vol.56, No.18, 2455-2461, 2017.
(DOI: 10.2169/internalmedicine.8223-16,   PubMed: 28824054,   Elsevier: Scopus)
10. Muto Kohei, Naoko Matsui, Unai Yuki, Sakai Waka, Haji Shotaro, Udaka Kengo, Hirokazu Miki, Takahiro Furukawa, Masahiro Abe and Ryuji Kaji :
Memory B cell resurgence requires repeated rituximab in myasthenia gravis,
Neuromuscular Disorders, Vol.27, No.16, 918-922, 2017.
(DOI: 10.1016/j.nmd.2017.06.012,   PubMed: 28694074)
11. Jun Okazaki, Naoki Muguruma, Shinji Kitamura, Tetsuo Kimura, Koichi Okamoto, Hiroshi Miyamoto, Kazuhiro Kishi, Yoshimi Bando, Takeshi Kondo, Itsuro Endo, Masahiro Abe and Tetsuji Takayama :
Paraneoplastic hypocalcemia developed in gastric cancer accompanied by osteoblastic metastasis,
Internal Medicine, Vol.56, No.11, 1345-1349, 2017.
(DOI: 10.2169/internalmedicine.56.8545,   PubMed: 28566596,   Elsevier: Scopus)
12. Kiyoe Kurahashi, Seika Inoue, Sumiko Yoshida, Yasumasa Ikeda, Kana Morimoto, Ryoko Uemoto, Kazue Ishikawa, Takeshi Kondo, Tomoyuki Yuasa, Itsuro Endo, Masato Miyake, Seiichi Oyadomari, Toshio Matsumoto, Masahiro Abe, Hiroshi Sakaue and Ken-ichi Aihara :
The Role of Heparin Cofactor in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice.,
Journal of Atherosclerosis and Thrombosis, 2017.
(DOI: 10.5551/jat.37739,   PubMed: 28502917)
13. Akio Kuroda, Tsuruo Miho, Aki Nanako, Takeshi Kondo, Oguro Yukari, Motoyuki Tamaki, Ken-ichi Aihara, Itsuro Endo, Toshio Matsumoto, Masahiro Abe and Munehide Matsuhisa :
A Pirot study comparing the CGM-assessed glycemic profiles of patients with type 1 diabetes on insulin degludec and insulin glargine,
Diabetology International, Vol.8, No.1, 112-115, 2017.
(DOI: 10.1007/s13340-016-0289-4,   Elsevier: Scopus)
14. Takeshi Kondo, Itsuro Endo, Yukari Ooguro, Kana Morimoto, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto :
Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer.,
Internal Medicine, Vol.55, No.24, 3623-3626, 2016.
(DOI: 10.2169/internalmedicine.55.7359,   PubMed: 27980263,   Elsevier: Scopus)
15. Ariunzaya Bat-Erdene, Hirokazu Miki, Asuko Oda, Shingen Nakamura, Jumpei Teramachi, Ryota Amachi, Hirofumi Tenshin, Masahiro Hiasa, Masami Iwasa, Takeshi Harada, Shiroh Fujii, Kimiko Sogabe, Kumiko Kagawa, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara and Masahiro Abe :
Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors.,
Oncotarget, Vol.7, No.48, 79064-79075, 2016.
(Tokushima University Institutional Repository: 113049,   DOI: 10.18632/oncotarget.12594,   PubMed: 27738323)
16. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, Takeshi Harada, Asuka Oda, Shingen Nakamura, Derek Hanson, Keiichiro Watanabe, Shiroh Fujii, Hirokazu Miki, Kumiko Kagawa, Masami Iwasa, Itsuro Endo, Takeshi Kondo, Sumiko Yoshida, Ken-ichi Aihara, Kiyoe Kurahashi, Yoshiaki Kuroda, Hideaki Horikawa, Eiji Tanaka, Masahiro Abe and Toshio Matsumoto :
A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration.,
Oncotarget, Vol.7, No.43, 70447-70461, 2016.
(Tokushima University Institutional Repository: 113048,   DOI: 10.18632/oncotarget.11927,   PubMed: 27626482)
17. Takeshi Harada, Hirokazu Miki, Q Cui, A Oda, Ryota Amachi, Jumpei Teramachi, A Bat-Erdene, K Sogabe, M Iwasa, Shiroh Fujii, Shingen Nakamura, Kumiko Kagawa, Sumiko Yoshida, I Endo, Ken-ichi Aihara, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Expansion of Th1-like V9V2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid.,
Leukemia, Vol.31, No.1, 258-262, 2016.
(DOI: 10.1038/leu.2016.273,   PubMed: 27698446)
18. Naoto Okada, Takeshi Hanafusa, Shinji Abe, Chiemi Sato, Toshimi Nakamura, Kazuhiko Teraoka, Masahiro Abe, Kazuyoshi Kawazoe and Keisuke Ishizawa :
Evaluation of the risk factors associated with high-dose chemotherapyinduced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: Possible usefulness of cryotherapy in dysgeusia prevention,
Supportive Care in Cancer, Vol.24, No.9, 3979-3985, 2016.
(DOI: 10.1007/s00520-016-3244-9,   PubMed: 27129837)
19. Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara, Ohnishi Yukiyo, Dong Bingzi, Oguro Yukari, Kiyoe Kurahashi, Sumiko Yoshida, Yuichi Fujinaka, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Toshio Matsumoto and Masahiro Abe :
Serum carboxy-terminal telopeptide of type I collagen levels are associated with carotid atherosclerosis in patients with cardiovascular risk factors.,
Endocrine Journal, Vol.63, No.4, 397-404, 2016.
(DOI: 10.1507/endocrj.EJ15-0589,   PubMed: 26877258,   Elsevier: Scopus)
20. Naoto Okada, Shuji Fushitani, Momoyo Azuma, Shingen Nakamura, Toshimi Nakamura, Kazuhiko Teraoka, Hiroyoshi Watanabe, Masahiro Abe, Kazuyoshi Kawazoe and Keisuke Ishizawa :
Clinical evaluation of pharmacist interventions in patients treated with anti-methicillin-resistant Staphylococcus aureus agents in a hematological ward,
Biological & Pharmaceutical Bulletin, Vol.39, No.2, 295-300, 2015.
(DOI: 10.1248/bpb.b15-00774,   PubMed: 26830489)
21. James Derek Hanson, Shingen Nakamura, Ryota Amachi, Masahiro Hiasa, Asuka Oda, Daisuke Tsuji, Kohji Itoh, Takeshi Harada, Kazuki Horikawa, Jumpei Teramachi, Hirokazu Miki, Toshio Matsumoto and Masahiro Abe :
Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation.,
Oncotarget, Vol.6, No.32, 33568-33586, 2015.
(DOI: 10.18632/oncotarget.5598,   PubMed: 26384349,   Elsevier: Scopus)
22. Michiko Yamashita, Yoshiyuki Fujii, Keiji Ozaki, Yoshio Urano, Masami Iwasa, Shingen Nakamura, Shiroh Fujii, Masahiro Abe, Yasuharu Sato and Tadashi Yoshino :
Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma.,
Diagnostic Pathology, Vol.10, 185, 2015.
(DOI: 10.1186/s13000-015-0419-5,   PubMed: 26449225,   Elsevier: Scopus)
23. Shingen Nakamura, Hirokazu Miki, Asuka Oda, Ryota Amachi, Jumpei Teramachi, Kimiko Sogabe, Hikaru Fujino, Tomoko Maruhashi, Shiroh Fujii, Kumiko Kagawa and Masahiro Abe :
Susceptibility to bendamustine considerably varies among myeloma cells, but is enhanced in acidic conditions,
International Journal of Myeloma, Vol.6, No.1, 7-11, 2015.
24. Bingzi Dong, Itsuro Endo, Yukiyo Ohnishi, Takeshi Kondo, Tomoka Hasegawa, Norio Amizuka, Hiroshi Kiyonari, Go Shioi, Masahiro Abe, Seiji Fukumoto and Toshio Matsumoto :
Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).,
Journal of Bone and Mineral Research, Vol.30, No.11, 1980-1993, 2015.
(DOI: 10.1002/jbmr.2551,   PubMed: 25967373,   Elsevier: Scopus)
25. Jin Temma, Munehide Matsuhisa, Toru Horie, Akio Kuroda, Hiroyasu Mori, Motoyuki Tamaki, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe and Toshio Matsumoto :
Non-invasive Measurement of Skin Autofluorescence as a Beneficial Surrogate Marker for Atherosclerosis in Patients with Type 2 Diabetes,
The Journal of Medical Investigation : JMI, Vol.62, No.3-4, 126-129, 2015.
(Tokushima University Institutional Repository: 111266,   DOI: 10.2152/jmi.62.126,   PubMed: 26399335,   Elsevier: Scopus)
26. T Watanabe, M Mitsuhashi, M Sagawa, M Ri, K Suzuki, Masahiro Abe, K Ohmachi, Y Nakagawa, Shingen Nakamura, S Iida and M Kizaki :
Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma,
PLoS ONE, Vol.10, No.6, e0128662, 2015.
(DOI: 10.1371/journal.pone.0128662,   PubMed: 26115406,   Elsevier: Scopus)
27. Hirokazu Miki, Shingen Nakamura, A Oda, R Amachi, Keiichiro Watanabe, D Hanson, Jumpei Teramachi, Masahiro Hiasa, H Yagi, K Sogabe, M Takahashi, T Maruhashi, K Udaka, T Harada, Shiroh Fujii, A Nakano, Kumiko Kagawa, M Ri, S Iida, Shuji Ozaki, T Matsumoto and Masahiro Abe :
Induction of endoplasmic reticulum stress by bortezomib sensitizes myeloma cells to DR5-mediated cell death,
International Journal of Myeloma., Vol.5, No.1, 1-7, 2015.
28. Koichiro Hayashi, Michihiro Nakamura, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto, Sakamoto Wataru, Yogo Toshinobu and Kazunori Ishimura :
Magnetically Responsive Smart Nanoparticles for Cancer Treatment with a Combination of Magnetic Hyperthermia and Remote-Control Drug Release,
Theranostics, Vol.4, No.8, 834-844, 2014.
(DOI: 10.7150/thno.9199,   PubMed: 24955144,   Elsevier: Scopus)
29. Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki and Masahiro Abe :
Successful treatment of refractory severe aplastic anemia with bone marrow transplantation from a genetically identical twin,
Shikoku Acta Medica, Vol.70, No.3,4, 77-80, 2014.
(Tokushima University Institutional Repository: 109757,   CiNii: 40020209360)
30. Naoto Okada, Takeshi Hanafusa, Takumi Sakurada, Kazuhiko Teraoka, Toshihide Kujime, Masahiro Abe, Yasuo Shinohara, Kazuyoshi Kawazoe and Kazuo Minakuchi :
Risk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-CHOP or R-CHOP-Like Chemotherapy,
Journal of Clinical Medicine Research, Vol.6, No.4, 252-260, 2014.
(DOI: 10.14740/jocmr1856w,   PubMed: 24883150)
31. Masahiro Hiasa, Jumpei Teramachi, A Oda, Ryota Amachi, T Harada, Shingen Nakamura, Hirokazu Miki, Shiroh Fujii, Kumiko Kagawa, Keiichiro Watanabe, Itsuro Endo, Y Kuroda, T Yoneda, Daisuke Tsuji, Michiyasu Nakao, Eiji Tanaka, Kenichi Hamada, Shigeki Sano, Kouji Itou, Toshio Matsumoto and Masahiro Abe :
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.,
Leukemia, 2014.
(DOI: 10.1038/leu.2014.147,   PubMed: 24787487)
32. Masahiro Abe, Takeshi Harada and Toshio Matsumoto :
Concise review: Defining and targeting myeloma stem cell-like cells.,
Stem Cells, Vol.32, No.5, 1067-1073, 2014.
(DOI: 10.1002/stem.1643,   PubMed: 24449391)
33. Koichiro Hayashi, Michihiro Nakamura, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto, Toshinari Kori and Kazunori Ishimura :
Photostable Iodinated Silica/Porphyrin Hybrid Nanoparticles with Heavy-Atom Effect for Wide-Field Photodynamic/Photothermal Therapy Using Single Light Source,
Advanced Functional Materials, Vol.24, No.4, 503-513, 2014.
(DOI: 10.1002/adfm.201301771,   Elsevier: Scopus)
34. Takeshi Harada, Shuji Ozaki, Asuka Oda, Daisuke Tsuji, Akishige Ikegame, Masami Iwasa, Kengo Udaka, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Yoshiaki Kuroda, Shigeto Kawai, Kouji Itou, Hisafumi Yamada-Okabe, Toshio Matsumoto and Masahiro Abe :
Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors,
PLoS ONE, Vol.8, No.12, e83905, 2013.
(DOI: 10.1371/journal.pone.0083905,   PubMed: 24386306,   Elsevier: Scopus)
35. Masahiro Abe :
Bench work for targeted therapy to the microenvironment of myeloma bone disease.,
Clinical Lymphoma, Myeloma & Leukemia, Vol.14, No.1, 8-9, 2013.
(DOI: 10.1016/j.clml.2013.12.006,   PubMed: 24461802)
36. Naoto Okada, Kazuyoshi Kawazoe, Kazuhiko Teraoka, Toshihide Kujime, Masahiro Abe, Yasuo Shinohara and Kazuo Minakuchi :
Identification of the Risk Factors Associated with Hypocalcemia Induced by Denosumab,
Biological & Pharmaceutical Bulletin, Vol.36, No.10, 1622-1626, 2013.
(DOI: 10.1248/bpb.b13-00496,   PubMed: 23934346,   CiNii: 130003361547,   Elsevier: Scopus)
37. Shingen Nakamura, Hirokazu Miki, Shinsuke Kido, Ayako Nakano, Masahiro Hiasa, Asuka Oda, Hiroe Amou, Keiichiro Watanabe, Takeshi Harada, Shiroh Fujii, Kyoko Takeuchi, Kumiko Kagawa, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Activating transcription factor 4, an ER stress mediator, is required for, but exce ssive ER stress suppresses osteoblastogenesis by bortezomib.,
International Journal of Hematology, Vol.98, No.1, 66-73, 2013.
(DOI: 10.1007/s12185-013-1367-z,   PubMed: 23708974,   Elsevier: Scopus)
38. Koichiro Hayashi, Michihiro Nakamura, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
Gold Nanoparticle Cluster/Plasmon-Enhanced Fluorescent Silica Core-Shell Nanoparticles for X-Ray Computed Tomography/Fluorescence Dual-Mode Imaging of Tumors,
Chemical Communications, Vol.49, 5334-5336, 2013.
(DOI: 10.1039/c3cc41876f,   PubMed: 23648868)
39. Koichiro Hayashi, Michihiro Nakamura, Wataru Sakamoto, Toshinobu Yogo, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
"Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment,
Theranostics, Vol.3, No.6, 366-376, 2013.
(DOI: 10.7150/thno.5860,   PubMed: 23781284,   Elsevier: Scopus)
40. Shuji Kato, Itsuro Endo, Mitsunori Fujimura, Rika Kuriwaka-Kido, Yuichi Fujinaka, Ken-ichi Aihara, Takashi Iwase, Daisuke Inoue, Masashi Akaike, Masahiro Abe and Toshio Matsumoto :
Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: A pilot study.,
Atherosclerosis, Vol.229, No.1, 182-185, 2013.
(DOI: 10.1016/j.atherosclerosis.2013.03.030,   PubMed: 23639859)
41. Koichiro Hayashi, Michihiro Nakamura, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
Near-Infrared Fluorescent Silica/Porphyrin Hybrid Nanorings for In Vivo Cancer Imaging,
Advanced Functional Materials, Vol.22, No.17, 3539-3546, 2012.
(DOI: 10.1002/adfm.201200219)
42. Tamotsu Kanbara, Hirotsugu Kurobe, Takashi Kitaichi, Mikio Sugano, Nakayama Taisuke, Hajime Kinoshita, Takashi Iwase, Akaike Masafumi, Masahiro Abe, Masataka Sata, Toshio Matsumoto and Tetsuya Kitagawa :
Autologous Peripheral Blood-Derived Mononuclear Cells Induced by Erythropoietin Improve Critical Ischemic Limbs.,
Annals of Vascular Diseases, Vol.5, No.1, 52-60, 2012.
(DOI: 10.3400/avd.oa.11.00070,   PubMed: 23555486)
43. Kumiko Kagawa, Ayako Nakano, Hirokazu Miki, Asuka Oda, Hiroe Amou, Kyoko Takeuchi, Shingen Nakamura, Takeshi Harada, Shiro Fujii, Kenichiro Yata, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.,
PLoS ONE, Vol.7, No.2, 2012.
(DOI: 10.1371/journal.pone.0031594,   PubMed: 22389670)
44. Ayako Nakano, Hirokazu Miki, Shingen Nakamura, Takeshi Harada, Asuka Oda, Hiroe Amou, Shiro Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate.,
Journal of Bioenergetics and Biomembranes, Vol.44, No.1, 31-38, 2012.
(DOI: 10.1007/s10863-012-9412-9,   PubMed: 22298254)
45. Yawara Kawano, Shikiko Ueno, Masahiro Abe, Yoshitaka Kikukawa, Hiromichi Yuki, Kenichi Iyama, Yutaka Okuno, Hiroaki Mitsuya and Hiroyuki Hata :
TRAIL produced from multiple myeloma cells is associated with osteolytic markers.,
Oncology Reports, Vol.27, No.1, 39-44, 2012.
(DOI: 10.3892/or.2011.1491,   PubMed: 21993926)
46. Keisuke Fujioka, Atsuro Saijo, Yuko Toyoda, Souji Kakiuchi, Masaki Hanibuchi, Masahiko Azuma, Kyoko Takeuchi, Shiroh Fujii, Shingen Nakamura, Kengo Utaka, Kumiko Kagawa, Masahiro Abe, Tomoya Mizutani and Yasuhiko Nishioka :
皮膚ランダム生検が診断に有用であった血管内リンパ腫の一例,
Shikoku Acta Medica, Vol.67, No.5,6, 257-262, 2011.
(Tokushima University Institutional Repository: 97858,   CiNii: 40019180117)
47. Ayako Nakano, Daisuke Tsuji, Hirokazu Miki, Qu Cui, Mohamed Sayed Salah El, Akishige Ikegame, Asuka Oda, Hiroe Amou, Shingen Nakamura, Takeshi Harada, Shiro Fujii, Kumiko Kagawa, Kyoko Takeuchi, Akira Sakai, Shuji Ozaki, Kazuma Okano, Takahiro Nakamura, Kouji Itou, Toshio Matsumoto and Masahiro Abe :
Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells.,
PLoS ONE, Vol.6, No.11, 2011.
(DOI: 10.1371/journal.pone.0027222,   PubMed: 22073292)
48. Hirokazu Miki, Shingen Nakamura, Shuji Ozaki, A Oda, H Amou, Akishige Ikegame, Keiichiro Watanabe, Masahiro Hiasa, Q Cui, T Harada, Shiroh Fujii, A Nakano, Kumiko Kagawa, Kyoko Takeuchi, Ken-ichiro Yata, A Sakai, Masahiro Abe and Toshio Matsumoto :
KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts.,
British Journal of Haematology, Vol.155, No.3, 328-339, 2011.
(DOI: 10.1111/j.1365-2141.2011.08844.x,   PubMed: 21902681)
49. Masahiro Abe :
Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma.,
International Journal of Hematology, Vol.94, No.4, 334-343, 2011.
(DOI: 10.1007/s12185-011-0949-x,   PubMed: 22005835)
50. Masahiro Abe :
Guest editorial: understanding the pathogenesis and the evolving treatment paradigm for multiple myeloma in the era of novel agents.,
International Journal of Hematology, Vol.94, No.4, 307-309, 2011.
(DOI: 10.1007/s12185-011-0950-4,   PubMed: 21993876)
51. Qu Cui, Hironobu Shibata, Asuka Oda, Hiroe Amou, Ayako Nakano, Kenichiro Yata, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Takeshi Harada, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Targeting myeloma-osteoclast interaction with V9V2 T cells.,
International Journal of Hematology, Vol.94, No.1, 63-70, 2011.
(DOI: 10.1007/s12185-011-0885-9,   PubMed: 21698356)
52. Ayako Nakano, Masahiro Abe, Asuka Oda, Hiroe Amou, Masahiro Hiasa, Shingen Nakamura, Hirokazu Miki, Takeshi Harada, Shirou Fujii, Kumiko Kagawa, Kyoko Takeuchi, Takashi Watanabe, Shuji Ozaki and Toshio Matsumoto :
Delayed treatment with vitamin C and N-acetyl-L: -cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib.,
International Journal of Hematology, Vol.93, No.6, 727-735, 2011.
(DOI: 10.1007/s12185-011-0850-7,   PubMed: 21526377)
53. J Asano, A Nakano, A Oda, H Amou, Masahiro Hiasa, Kyoko Takeuchi, H Miki, S Nakamura, T Harada, Shiroh Fujii, Kumiko Kagawa, Itsuro Endo, Ken-ichiro Yata, A Sakai, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.,
Leukemia, 2011.
(DOI: 10.1038/leu.2011.60,   PubMed: 21475253)
54. Shuji Ozaki, Takeshi Harada, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Ayako Nakano, Kumiko Kagawa, Kyoko Takeuchi, Masahiro Abe and Toshio Matsumoto :
Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma.,
International Journal of Hematology, Vol.93, No.2, 257-259, 2011.
(DOI: 10.1007/s12185-011-0775-1,   PubMed: 21279817)
55. Michihiro Nakamura, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
One-pot synthesis and characterization of dual fluorescent thiol-organosilica nanoparticles as non-photoblinking quantum dots and their applications for biological imaging,
Journal of Materials Chemistry, Vol.21, 4689-4695, 2011.
(DOI: 10.1039/C0JM04259E)
56. Shunji Hashizume, Masashi Akaike, Hiroyuki Azuma, Kazue Ishikawa, Sumiko Yoshida, Yuka Ueda, Shusuke Yagi, Yasumasa Ikeda, Takashi Iwase, Ken-ichi Aihara, Masahiro Abe, Masataka Sata and Toshio Matsumoto :
Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets.,
Journal of Atherosclerosis and Thrombosis, Vol.18, No.2, 138-147, 2011.
(DOI: 10.5551/jat.5868,   PubMed: 21060209)
57. Takako Taniguchi, Shinsuke Kido, Emiko Yamauchi, Masahiro Abe, Toshio Matsumoto and Hisaaki Taniguchi :
Induction of endosomal/lysosomal pathways in differentiating osteoblasts as revealed by combined proteomic and transcriptomic analyses.,
FEBS Letters, Vol.584, No.18, 3969-3974, 2010.
(DOI: 10.1016/j.febslet.2010.07.055,   PubMed: 20682313)
58. Shingen Nakamura, Kenichiro YATA, Tadashi JINNO, Takeshi HARADA, Shiro FUJII, Hirokazu MIKI, Ayako NAKANO, Kumiko KAGAWA, Kyoko TAKEUCHI, Shuji OZAKI, Masahiro Abe and Toshio MATSUMOTO :
Multiple myeloma complicated with disseminated zygomycosis after bortezomib therapy,
The Japanese Journal of Clinical Hematology, Vol.51, No.8, 690-695, 2010.
(DOI: 10.11406/rinketsu.51.690,   PubMed: 20805677,   CiNii: 130004501433,   Elsevier: Scopus)
59. Michihiro Nakamura, Shuji Ozaki, Masahiro Abe, Hiroyuki Doi, Toshio Matsumoto and Kazunori Ishimura :
Size-controlled synthesis, surface functionalization, and biological applications of thiol-organosilica particles.,
Colloids and Surfaces B:Biointerfaces, Vol.79, No.1, 19-26, 2010.
(DOI: 10.1016/j.colsurfb.2010.03.008,   PubMed: 20417071)
60. Kyoko Takeuchi, Masahiro Abe, Masahiro Hiasa, Asuka Oda, Hiroe Amou, Shinsuke Kido, Takeshi Harada, Osamu Tanaka, Hirokazu Miki, Shingen Nakamura, Ayako Nakano, Kumiko Kagawa, Kenichiro Yata, Shuji Ozaki and Toshio Matsumoto :
Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth.,
PLoS ONE, Vol.5, No.3, e9870, 2010.
(DOI: 10.1371/journal.pone.0009870,   PubMed: 20360846)
61. Masahiro Hiasa, Masahiro Abe, Ayako Nakano, Asuka Oda, Hiroe Amou, Shinsuke Kido, Kyoko Takeuchi, Kumiko Kagawa, Kenichiro Yata, Toshihiro Hashimoto, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka, Keiji Moriyama and Toshio Matsumoto :
GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-{alpha} converting enzyme (TACE),
Blood, Vol.114, No.20, 4517-4526, 2009.
(DOI: 10.1182/blood-2009-04-215020,   PubMed: 19762488)
62. Ken-ichi Kitazoe, Masahiro Abe, Masahiro Hiasa, Asuka Oda, Hiroe Amou, Takeshi Harada, Ayako Nakano, Kyoko Takeuchi, Toshihiro Hashimoto, Ken-ichiro Yata, Shuji Ozaki and Toshio Matsumoto :
Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma.,
International Journal of Hematology, Vol.89, No.1, 45-57, 2008.
(DOI: 10.1007/s12185-008-0226-9,   PubMed: 19093163)
63. Youichi Tanaka, Masahiro Abe, Masahiro Hiasa, Asuka Oda, Hiroe Amou, Ayako Nakano, Kyoko Takeuchi, Kenichi Kitazoe, Shinsuke Kido, Daisuke Inoue, Keiji Moriyama, Toshihiro Hashimoto, Shuji Ozaki and Toshio Matsumoto :
Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin,
Clinical Cancer Research, Vol.13, No.3, 816-823, 2007.
(DOI: 10.1158/1078-0432.CCR-06-2258,   PubMed: 17289872)
64. Masahiro Abe, Shinsuke Kido, Masahiro Hiasa, Nakano Ayako, Oda Asuka, Amou Hiroe and Toshio Matsumoto :
BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc tratment in patients with multiple myeloma.,
Leukemia, Vol.20, No.7, 1313-1315, 2006.
(DOI: 10.1038/sj.leu.2404228,   PubMed: 16617317)
65. Ali Jalili, Shuji Ozaki, Tomoko Hara, Hironobu Shibata, Toshihiro Hashimoto, Masahiro Abe, Yasuhiko Nishioka and Toshio Matsumoto :
Induction of HM1.24 peptide specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma,
Blood, Vol.106, No.10, 3538-3545, 2005.
(DOI: 10.1182/blood-2005-04-1438,   PubMed: 16037388)
66. Takashi Oshima, Masahiro Abe, Jin Asano, Tomoko Hara, Kenichi Kitazoe, Etsuko Sekimoto, Yoichi Tanaka, Hironobu Shibata, Toshihiro Hashimoto, Shuji Ozaki, Shinsuke Kido, Daisuke Inoue and Toshio Matsumoto :
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2,
Blood, Vol.106, No.9, 3160-3165, 2005.
(DOI: 10.1182/blood-2004-12-4940,   PubMed: 16030194)
67. Hironobu Shibata, Masahiro Abe, Kenji Hiura, Javier Wilde, Keiji Moriyama, Toshiaki Sano, Ken-ichi Kitazoe, Toshihiro Hashimoto, Shuji Ozaki, Shingo Wakatsuki, Shinsuke Kido, Daisuke Inoue and Toshio Matsumoto :
Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.,
Clinical Cancer Research, Vol.11, No.17, 6109-6115, 2005.
(DOI: 10.1158/1078-0432.CCR-05-0181,   PubMed: 16144909)
68. Shoji Sakiyama, Kazuya Kondo, Mitsuteru Yoshida, Hiromitsu Takizawa, Koichiro Kenzaki, Takanori Miyoshi, Masahiro Abe, Shingo Wakatsuki and Yasumasa Monden :
Extramedullary plasmacytoma immunoglobulin D (λ) in the chest wall and the subglottic region,
Journal of Thoracic and Cardiovascular Surgery, Vol.129, No.5, 1168-1169, 2005.
(DOI: 10.1016/j.jtcvs.2004.08.037,   PubMed: 15867795)
69. Toshio Matsumoto and Masahiro Abe :
The Importance of Notch Signaling in Myeloma Cell-Osteoclast Interactions,
BoneKEy Osteovision, Vol.2, No.2, 7-10, 2005.
(DOI: 10.1138/20050148)
70. Naoki Kimura, Shigeto Kawai, Yasuko Kinoshita, Takahiro Ishiguro, Yumiko Azuma, Shuji Ozaki, Masahiro Abe, Masamichi Sugimoto, Yuichi Hirata, Tetsuro Orita, Hisafumi Okabe, Toshio Matsumoto and Masayuki Tsuchiya :
2D7 diabody bound to the α2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells,
Biochemical and Biophysical Research Communications, Vol.325, No.4, 1201-1209, 2004.
(DOI: 10.1016/j.bbrc.2004.10.163,   PubMed: 15555554)
71. Masahiro Abe, Kenji Hiura, Javier Wilde, Atsushi Shioyasono, Keiji Moriyama, Toshihiro Hashimoto, Shinsuke Kido, Takashi Oshima, Hironobu Shibata, Shuji Ozaki, Daisuke Inoue and Toshio Matsumoto :
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion.,
Blood, Vol.104, No.8, 2484-2491, 2004.
(DOI: 10.1182/blood-2003-11-3839,   PubMed: 15187021)
72. Hirokazu Murakami, Hiroshi Fujii, Tohru Inaba, Chihiro Shimazaki, Sinichirou Okamoto, Akiyosi Miwa, Morio Sawamura, Masahiro Abe, Takaaki Chou, Hideki Asaoku, Yoshikazu Kitahara, Kunihiko Hayashi, Masaaki Kosaka, Atsushi Togawa and Kiyoshi Takatsuki :
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma,
European Journal of Haematology, Vol.73, No.3, 169-173, 2004.
(DOI: 10.1111/j.1600-0609.2004.00282.x,   PubMed: 15287913)
73. Toshihiro Hashimoto, Masahiro Abe, Takashi Oshima, Hironobu Shibata, Shuji Ozaki, Daisuke Inoue and Toshio Matsumoto :
Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1α and MIP-1β correlates with lytic bone lesions in patients with multiple myeloma,
British Journal of Haematology, Vol.125, No.1, 38-41, 2004.
(DOI: 10.1111/j.1365-2141.2004.04864.x,   PubMed: 15015966)
74. Tomoko Hara, Shingo Wakatsuki, Shuji Ozaki, Masahiro Abe and Masaaki Kosaka :
Primary adult T-cell leukemia/lymphoma of bone,
International Journal of Hematology, Vol.79, No.2, 157-160, 2004.
(DOI: 10.1532/IJH97.03006,   PubMed: 15005344,   CiNii: 10012093736)
75. Mitsunori Fujimura, Masashi Akaike, Midori Kato, Nobuyuki Takamori, Masahiro Abe, Takeshi Nishiuchi, Hiroyuki Azuma and Toshio Matsumoto :
Aggressive antiplatelet therapy before coronary stent implantation in acute coronary syndrome with essential thrombocythemia--a case report,
Angiology, Vol.54, No.4, 485-490, 2003.
(DOI: 10.1177/000331970305400414,   PubMed: 12934770)
76. Masahiro Abe, Kenji Hiura, Javier Wilde, Keiji Moriyama, Toshihiro Hashimoto, Shuji Ozaki, Shingo Wakatsuki, Masaaki Kosaka, Shinsuke Kido, Daisuke Inoue and Toshio Matsumoto :
Role for macrophage inflammatory protein (MIP)-1α and MIP-1β in the development of osteolytic lesions in multiple myeloma,
Blood, Vol.100, No.6, 2195-2202, 2002.
(PubMed: 12200385,   Elsevier: Scopus)
77. Masahiro Abe, Yasumi Shintani, Yuzuru Eto, Kazuyo Harada, Masaaki Kosaka and Toshio Matsumoto :
Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells,
Journal of Leukocyte Biology, Vol.72, No.2, 347-352, 2002.
(PubMed: 12149426,   Elsevier: Scopus)
78. Masahiro Abe, Yasumi Shintani, Yuzuru Eto, Kazuyo Harada, Yuichi Fujinaka, Masaaki Kosaka and Toshio Matsumoto :
Interleukin-1 β enhances and interferon-γ suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts,
Clinical and Experimental Immunology, Vol.126, No.1, 64-68, 2001.
(DOI: 10.1046/j.1365-2249.2001.01644.x,   PubMed: 11678900,   Elsevier: Scopus)
79. Masahiro Abe, Y Shintani, Y Eto, K Harada, Y Fujinaka, M Kosaka and Toshio Matsumoto :
Interleukin 1β enhances and interferon-γ suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts,
Clinical and Experimental Immunology, Vol.126, 64-68, 2001.
80. Ken-ichi Aihara, Hiroyuki Azuma, Yasumasa Ikeda, Masashi Akaike, Masahiro Abe, Takashi Sugihara and Toshio Matsumoto :
Successful combination therapy--flunarizine,pentoxifylline, and cholestyramine--for spur cell anemia,
International Journal of Hematology, Vol.73, No.3, 351-355, 2001.
(PubMed: 11345202)
81. Mototsugu Kato, Masahiro Asaka, Masao Saito, Hitoshi Sekine, Shuichi Ohara, Takayoshi Toyota, Taiji Akamatsu, Taimei Kaneko, Kendo Kiyosawa, Osamu Nishizawa, Toshiko Kumagai, Tsutomu Katsuyama, Masahiro Abe, Masaaki Kosaka, Shojiro Hariya, Kunihiro Minami, Yasuhiro Sanai, Masayuki Sawamura and Tetsuya Tachikawa :
Clinical Usefulness of Urine-based Enzyme-linked Immunosorbent Assay for Detection of Antibody to Helicobacter pylori:A Collaborative Study in Nine Medical Institutions in Japan,
Helicobacter, Vol.5, No.2, 109, 2000.
(DOI: 10.1046/j.1523-5378.2000.00017.x,   PubMed: 10849061,   Elsevier: Scopus)
82. Shuji Ozaki, Masaaki Kosaka, Shingo Wakatsuki, Masahiro Abe, Yasuo Koishihara and Toshio Matsumoto :
Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24,
Blood, Vol.90, No.8, 3179-3186, 1997.
83. Zhong-Hui Liu, Yasumi Shintani, Yukihiro Sakamoto, Kazuyo Harada, Chen-Yu Zhang, Yuichi Fujinaka, Masahiro Abe, Tetsuya Goto and Shiro Saito :
Effects of LHRH, FSH and activin A on follistatin secretion from cultured rat anterior pituitary cells,
Endocrine Journal, Vol.43, No.3, 321-327, 1996.
(DOI: 10.1507/endocrj.43.321,   PubMed: 8886627)
84. Hisaomi Kawai, Kenji Yokoi, Masashi Akaike, Makoto Kunishige, Masahiro Abe, Y Tanouchi, Hideki Mine, Y Mimura and Shiro Saito :
Graves' disease in HTLV-I carriers,
Journal of molecular medicine, Vol.73, No.2, 85-88, 1995.
85. Masahiro Abe, Tetsuya Goto, Shuji Ozaki, Masaaki Kosaka and Solomon Alan :
Enzyme-linked immunosorbent assay for variable region γ subgroup of light chain in serum:method and results in normal subjects and patients with hyper-and hypogammaglobulinemia,
日本臨床免疫学会会誌, Vol.17, No.3, 172-181, 1994.
86. Shuji Ozaki, Masahiro Abe, Dennis Wolfenbarger, Deborah T. Weiss and Alan Solomon :
Preferential Expression of Human λ-Light-Chain Variable-Region Subgroups in Multiple Myeloma, AL Amyloidosis, and Waldenström's Macroglobulinemia,
Clinical Immunology and Immunopathology, Vol.71, No.2, 183-189, 1994.
87. 横井 健治, 川井 尚臣, 峯 秀樹, Masashi Akaike, Masahiro Abe, 国重 誠, Takao Mitsui and 斎藤 史郎 :
バセドウ病を発症したHTLV-Iキャリアの2家系3症例,
ホルモンと臨床, Vol.42, 94-97, 1994.
88. Masahiro Abe, Shuji Ozaki, Dennis Wolfenbarger, Mary deBram-Hart, Deborah T Weiss and Alan Solomon :
Variable-region subgroup distribution among lambda-type immunoglobulins in normal human serum,
Journal of Clinical Laboratory Analysis, Vol.8, No.1, 4-9, 1994.
(PubMed: 8164110)

Academic Paper (Unrefereed Paper):

1. Shingen Nakamura, Masahiro Abe and Toshio Matsumoto :
Part7. 2. 新規治療薬の開発と臨床応用の可能性を探る (抗RANKL抗体などを中心に). がん骨転移治療 ビスフォスフォネート治療によるBone Management,
先端医学者 高橋俊二 編集, 206-214, 2012.
2. Itsuro Endo, Masahiro Abe and Toshio Matsumoto :
骨転移の分子標的治療薬 骨転移のバイオロジーとマネージメント,
医薬ジャーナル社 米田俊之 編集, 215-224, 2012.
3. 七條 加奈, 関本 悦子, 三原 愛, 大田 加与, 田中 洋一, 大島 隆志, 柴田 泰伸, Toshihiro Hashimoto, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and 若槻 真吾 :
Successful treatment of relapsed/refractory Hodgkin's lymphoma with tandem transplantation,
The Journal of the Japanese Society of Internal Medicine, Vol.93, No.10, 2210-2212, 2004.
(DOI: 10.2169/naika.93.2210,   CiNii: 10014293411)
4. Masahiro Abe, Toshio Matsumoto and 小阪 昌明 :
Effect of bisphosphonate on myeloma bone disease,
The Japanese Journal of Clinical Hematology, Vol.43, No.5, 349-352, 2002.
(CiNii: 10010364770)

Review, Commentary:

1. Masahiro Abe :
Recent Advances in Biology and Treatment of Multiple Myeloma,
The Journal of the Japanese Society of Internal Medicine, Vol.104, No.2, 305-313, Feb. 2015.
(DOI: 10.2169/naika.104.305,   PubMed: 26571712,   CiNii: 130005125523)
2. Masahiro Abe :
デノスマブの作用機構とその臨床応用,
化学評論社, Vol.70, No.2, 279-284, Feb. 2015.
3. Shingen Nakamura and Masahiro Abe :
骨髄腫骨病変の治療,
血液内科, Vol.69, No.4, 525-533, Oct. 2014.
4. Masahiro Abe :
多発性骨髄腫の骨病変,
Clinical Calcium, Vol.24, No.8, 35-44, Aug. 2014.
5. Masahiro Abe :
骨髄腫の骨病変とサイトカイン,
Clinical Calcium, Vol.24, No.6, 69-76, Jun. 2014.
6. Masahiro Abe :
新しい診断と治療のABC 84「多発性骨髄腫」概念:MGUS,くすぶり型から症候性骨髄腫,
The Medical Frontline, 5-23, Jun. 2014.
7. Masahiro Abe :
多発性骨髄腫の骨病変形成機序とその治療,
腎と骨代謝, Vol.27, No.1, 33-40, Jan. 2014.
8. Masahiro Abe :
[Secondary osteoporosis or secondary contributors to bone loss in fracture. Bone metabolism in hematological disorders].,
Clinical Calcium, Vol.23, No.9, 1271-1277, Sep. 2013.
(PubMed: 23999362)
9. Masahiro Abe :
[Myeloma bone disease].,
The Japanese Journal of Clinical Hematology, Vol.54, No.8, 696-698, Aug. 2013.
(PubMed: 24005424)
10. Masahiro Abe :
[Wnt inhibitors and the suppression of bone formation in multiple myeloma].,
Clinical Calcium, Vol.23, No.6, 867-875, Jun. 2013.
(PubMed: 23719500)
11. Masahiro Abe :
[Development of the therapies targeting the interaction of myeloma cells with its bone marrow microenvironment].,
The Japanese Journal of Clinical Hematology, Vol.54, No.6, 522-532, Jun. 2013.
(PubMed: 23823090,   Elsevier: Scopus)
12. Masahiro Abe :
骨粗鬆症の類縁疾患とその治療,
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.71, No.2, 609-612, Apr. 2013.
13. Masahiro Abe :
Microenvironment for myeloma growth and drug resistance.,
International Journal of Myeloma, Vol.3, No.1, 2-11, Mar. 2013.
14. Masahiro Abe and Shingen Nakamura :
移植医療と骨粗鬆症,
THE BONE, Vol.27, No.2, 83-8, Feb. 2013.
15. Masahiro Abe :
[Blood disease and bone].,
Clinical Calcium, Vol.23, No.2, 256-262, Feb. 2013.
(PubMed: 23354094)
16. Masahiro Abe :
The RANKL antibody denosumab for the treatment of myeloma bone disease,
血液内科, Vol.65, No.4, 692-698, Nov. 2012.
(CiNii: 40019515670)
17. 藤井 志朗 and Masahiro Abe :
[Molecular targeting agents for multiple myeloma].,
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.70, No.8, 518-523, Nov. 2012.
(PubMed: 23513894,   Elsevier: Scopus)
18. 原田 武志 and Masahiro Abe :
プロテアソーム阻害薬の薬理作用,副作用と適応疾患,
血液内科, Vol.65, No.4, 530-537, Oct. 2012.
19. Masahiro Abe :
Bone disease in myeloma : mechanisms of bone destruction and novel targeted therapies,
Journal of Clinical and Experimental Medicine, Vol.242, No.13, 1068-1073, Sep. 2012.
(CiNii: 40019421949)
20. Eriko Obana, Masahiro Abe, Takenori Yamamoto and Yasuo Shinohara :
The importance of hexokinase in the energy metabolism of tumor cells,
Experimental Medicine, Vol.30, No.15, 36-41, Sep. 2012.
21. Masahiro Abe :
Mechanisms of bone destruction in myeloma,
Journal of Clinical and Experimental Medicine, Vol.242, No.9, 697-702, Sep. 2012.
(CiNii: 40019389630)
22. Masahiro Abe :
骨髄腫における骨破壊機構,
血液内科, Vol.64, No.4, 412-417, Apr. 2012.
23. Masahiro Abe :
Molecular biology of myeloma,
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.70, No.2, 577-583, Apr. 2012.
(PubMed: 23134018,   CiNii: 40019282929,   Elsevier: Scopus)
24. Kumiko Kagawa, Masahiro Abe and Toshio Matsumoto :
がん治療における骨の管理の重要性 がん骨転移治療 ビスフォスフォネート治療によるBone Management,
先端医学者 高橋俊二 編集, 16-21, 2012.
25. Masahiro Abe :
患者背景を踏まえた骨髄腫の治療戦略,
Myeloma & Lymphoma, Vol.4, 14-17, Sep. 2011.
26. Masahiro Abe and 松本 俊夫 :
RANKLと乳癌,
Cancer Board乳癌, Vol.4, No.2, 71-74, Sep. 2011.
27. Masahiro Abe :
Myeloma bone disease and RANKL signaling,
Clinical Calcium, Vol.21, No.8, 59-66, Aug. 2011.
(PubMed: 21814021)
28. 中村 信元 and Masahiro Abe :
多発性骨髄腫の合併症の管理 骨病変/局所病変の管理,
内科, Vol.108, No.2, 274-281, Aug. 2011.
29. Masahiro Abe :
腎障害を来す全身性疾患—最近の進歩 Ⅲパラプロテイン血症1.多発性骨髄腫,
内科学会雑誌, Vol.100, No.5, 1274-1281, May 2011.
30. Masahiro Abe :
多発性骨髄腫Update—診療の進歩と新規治療の展望 多発性骨髄腫の骨病変,
血液内科, Vol.62, No.3, 324-331, Mar. 2011.
31. Masahiro Abe :
多発性骨髄腫の骨病変のマネージメント,
日本骨髄腫研究会雑誌, Vol.1, No.1, 26-32, Mar. 2011.
32. 中村 信元 and Masahiro Abe :
骨病変に対する薬物療法と患者予後の改善効果,
血液フロンティア, Vol.21, No.1, 43-52, Jan. 2011.
33. Masahiro Abe :
多発性骨髄腫 Visual View 目でみるメカニズム,
Trands in Hematological Malignancies, Vol.2, No.4, 4-7, Dec. 2010.
34. Masahiro Abe :
サイトカインと骨髄腫骨病変,
CLINICAL CALCIUM, Vol.20, No.10, 26-32, Oct. 2010.
35. Masahiro Abe :
血液疾患における分子標的療法 ドラッグラグ解消に向けて,
血液フロンティア, Vol.20, No.S-1, 266-267, Sep. 2010.
36. Masahiro Abe :
現在開発中の多発性骨髄腫に対する治療薬,
Pharma Medica, Vol.28, No.9, 61-66, Sep. 2010.
37. Masahiro Abe :
Macrophages in myeloma bone marrow microenvironment induce drug resistance in myeloma cells,
血液・腫瘍科, Vol.61, No.2, 364-368, Aug. 2010.
(CiNii: 40019064119)
38. Masahiro Abe :
MGUS 内科疾患の診断基準・病型分類・重症度,
内科, Vol.105, No.6, 1458, Jun. 2010.
39. Masahiro Abe and 原田 武志 :
多発性骨髄腫 内科疾患の診断基準・病型分類・重症度,
Vol.105, No.6, 1429-1433, Jun. 2010.
40. Masahiro Abe :
多発性骨髄腫における血管新生と破骨細胞形成の促進,
細胞, Vol.42, No.2, 16-19, Mar. 2010.
41. Masahiro Abe :
多発性骨髄腫 造血間質(骨髄微小環境)から見た増殖動態,
カレントテラピー, Vol.28, No.3, 13-17, Mar. 2010.
42. Masahiro Abe :
M蛋白と骨髄腫-診断へのステップとピットフォール <セミナー>きめ細かい最新の検査・診断とその生かし方,
Medical Practice, Vol.27, No.2, 299-302, 2010.

Proceeding of International Conference:

1. Takeshi Harada, Asuka Oda, Hirofumi Tenshin, Jumpei Teramachi, Masahiro Oura, Kimiko Sogabe, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shuji Ozaki, Teru Hideshima, C. Kenneth Anderson and Masahiro Abe :
Targeting myeloma metabolisms regulated by HDAC1-IRF4 axis can be a novel therapeutic strategy,
17th International Myeloma Workshop, Sep. 2019.
2. Sumiko Yoshida, Ken-ichi Aihara and Masahiro Abe :
Eicosapentaenoic acid administration ameliorates cardiac remodeling in humans and protects against Ang II-induced cardiovascular remodeling via attenuation of oxidative stress in mice.,
Endocrine Society's Annual Meeting 2019, Mar. 2019.
3. Mohannad Ashtar, Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Kotaro Tanimoto, Oda Asuka, Iwasa Masami, Takeshi Harada, Bat-Erdene Ariunzaya, Kimiko Sogabe, Masahiro Oura, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
Peri-implantitis and the role of Febuxostat in osteoclast differentiation.,
AEEDC Dubai World Orthodontic Conference, Dubai, UAE, Feb. 2019.
4. Takeshi Harada, Asuka Oda, Yohann Grondin, Jumpei Teramachi, Ariunzaya Bat-Erdene, Masami Iwasa, Masahiro Oura, Shingen Nakamura, Kumiko Kagawa, Yasunobu Okamoto, Kimiko Sogabe, Shiroh Fujii, Hirokazu Miki, Shuji Ozaki, Teru Hideshima, Kenneth C. Anderson and Masahiro Abe :
The critical role of the HDAC1-IRF4-Pim-2 axis in myeloma cell growth and survival: therapeutic impacts of targeting the HDAC1-IRF4-Pim-2 axis,
60th ASH Annual Meeting & Exposition, San Diego, Dec. 2018.
5. Shingen Nakamura, Hirokazu Miki, Ariunzaya Bat-Erdene, Yasunobu Okamoto, Kimiko Sogabe, Masahiro Oura, Mamiko Takahashi, Masami Iwasa, Takeshi Harada, Shiroh Fujii, Kumiko Kagawa and Masahiro Abe :
Alteration of muscle mass after chemotherapy in patients with newly diagnosed multiple myeloma.,
Esmo asia 2018, Nov. 2018.
6. Yuichi Takashi, Yuka Kinoshita, Nobuaki Ito, Shun Sawatsubashi, Hidetaka Kosako, Masahiro Abe, Munehide Matsuhisa, Toshio Matsumoto and Seiji Fukumoto :
FGF receptor 1c works as a phosphate-sensor to regulate FGF23 production,
ASBMR 2018 Annual Meeting Registration Confirmation, Sep. 2018.
7. Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Oda Asuka, Bat-Erdene Ariunzaya, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Disruption of a progressive vicious cycle between myeloma tumor growth and bone destruction by TAK1 inhibition,
ASBMR 2018 Annual Meeting, Montreal, Sep. 2018.
8. Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Ashtar Mohannad, Kotaro Tanimoto, Iwasa Masami, Bat-Erdene Ariunzaya, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Opposite effects of TRAIL on the Sp-1-c-FLIP survival pathway in myeloma cells and osteoclasts.,
ASBMR 2018 Annual Meeting, Montreal, Sep. 2018.
9. Takeshi Harada, Oda Asuka, Jumpei Teramachi, Bat-Erdene Ariunzaya, Iwasa Masami, Oura Masahiro, Shingen Nakamura, Kumiko Kagawa, Okamoto Yasunobu, Kimiko Sogabe, Shiroh Fujii, Hirokazu Miki, Hideshima Teru, Anderson C. Kenneth and Masahiro Abe :
Selective inhibition of class-I HDAC induces myeloma cell death through targeting IRF4-Pim-2 axis,
The 9th JSH International Symposium 2018 in Kyoto, Jul. 2018.
10. Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Oda Asuka, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Tatsuji Haneji, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction,
8th International Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone and other Musculoskeletal Diseases and Cancer and Bone Society 2018 Meeting, Oxford, Jun. 2018.
11. Akio Kuroda, Misuzu Yamada, Yukari Tominaga, Reiko Suzuki, Motoyuki Tamaki, Yuko Akehi, Yuichi Takashi, Daisuke Otsuka, Eisuke Shimokita, Fuminori Tanihara, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe, Kevin Ferreri and Munehide Matsuhisa :
Detection of pancreatic beta cell DNA in the circulation using the amplification refractory mustation system PCR,
American Diabetes Association 78th Scientific Sessions, Orlando, Jun. 2018.
12. Hirofumi Tenshin, Jumpei Teramachi, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
Apoptosis inducer TRAIL stimulates osteoclast differentiation and survival via TAK1 activation.,
1st International Conference of Biophysical Technology in Dentistry (+10th International Scientific Meeting in Dentistry),, Makassar, Indonesia., Apr. 2018.
13. Sumiko Yoshida, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe :
Changes of oxidative stress markers in patient of diabetes educational hospitalization.,
The Endocrine Society's Annual Meeting 2018, Chicago, Mar. 2018.
14. Noboru Niki, Yoshiki Kawata, Hidenobu Suzuki, Mitsuo Shimada, Masafumi Harada, Issei Imoto, Masahiro Abe, Keiji Umetani, Masahiko Kusumoto, Keiju Aokage, Genichirou Ishii, Gen Iinuma, Yuuji Matsumoto, Yasutaka Nakano and Hiroaki Sakai :
Cancer diagnosis and prognosis assistance based on multidisciplinary computational anatomy - progress overview FY2017 -,
The 4nd International Symposium on Multidisciplinary Computational Anatomy, 107-114, Mar. 2018.
15. Hirofumi Tenshin, Jumpei Teramachi, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
Apoptosis inducer TRAIL stimulates osteoclast differentiation and survival via TAK1 activation.,
The 4th ASEAN plus Tokushima Joint International Conference, Bali, Indonesia, Dec. 2017.
16. Ken-ichi Aihara, Uemoto Ryoko, Ishikawa Kazue, Kana Morimoto, Kiyoe Kurahashi, Sumiko Yoshida, Tomoyuki Yuasa and Masahiro Abe :
Heparin cofactor II, a serine protease inhibitor, is associated with albuminuria in humans and mice.,
International Conference on Diabetes and Its Complications 2017, Baltimore, Nov. 2017.
17. Itsuro Endo, Dong Bingzi, Ohnishi Yukiyo, Kondo Takeshi, Masahiro Hiasa, Jumpei Teramachi, Toshio Matsumoto, Masahiro Abe, Seiji Fukumoto and Tatsuji Haneji :
Decreased bone strength induced by persistent activation of calcium-sensing receptor,
American Society for Bone and Mineral Research (ASBMR) 2017 Annual Meeting, Denver, Sep. 2017.
18. Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
TAK1 inhibition impairs myeloma cell-bone marrow interaction to reduce myeloma tumor growth and bone destruction,
American Society for Bone and Mineral Research (ASBMR) 2017 Annual Meeting, Denver, Sep. 2017.
19. Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction,
International Society for Experimental Hematology 46th Annual Scientific Meeting, Frankfurt, Aug. 2017.
20. Hirofumi Tenshin, Jumpei Teramachi, A Oda, Ryota Amachi, Masahiro Hiasa, A Baterdene, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Osteoclasts utilize TRAIL for their NF-B activation, but TAK1 inhibition resumes TRAIL-induced apoptosis in osteoclasts.,
Australian and New Zealand Bone and Mineral Society 2017, Brisbane, Australia., Jun. 2017.
21. Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Akihito Yamamoto, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction,
Cancer and Bone Society Conference 2017, Indianapolis, May 2017.
22. Ryota Amachi, Masahiro Hiasa, Oda Asuka, Bat-Erdene Ariunzaya, Jumpei Teramachi, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shiroh Fujii, Toshio Matsumoto, Eiji Tanaka and Masahiro Abe :
Osteoblast Creates a Non-permissive Niche for Myeloma Cells,
95th General Session & Exhibition of the IADR program book, San Francisco, Mar. 2017.
23. Hirofumi Tenshin, Jumpei Teramachi, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
TRAIL Stimulates Osteoclast Differentiation and Survival via TAK1 Activation.,
95th General Session & Exhibition of the IADR program book, San Francisco, Mar. 2017.
24. Noboru Niki, Yoshiki Kawata, Hidenobu Suzuki, Mitsuo Shimada, Masafumi Harada, Issei Imoto, Masahiro Abe, Keiji Umetani, Masahiko Kusumoto, Keiju Aokage, Genichirou Ishii, Gen Iinuma, Yuuji Matsumoto, Yasutaka Nakano and Hiroaki Sakai :
Cancer diagnosis and prognosis assistance based on multidisciplinary computational anatomy - Progress Overview FY2016 -,
The 3nd International Symposium on Multidisciplinary Computational Anatomy, 87-94, Mar. 2017.
25. Kiyoe Kurahashi, Itsuro Endo, Nakamura Maiko, Ohnishi Yukiyo, Takeshi Kondo, Aizawa Shinichi, Toshio Matsumoto, Seiji Fukumoto and Masahiro Abe :
Glucose intolerance induced by persistent activation of calcium-sensing receptor,
American Society for Bone and Mineral Research 2016 Annual Meeting, Atlanta, Sep. 2016.
26. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Kiyoe Kurahashi, Takeshi Kondo, Hirokazu Miki, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
TAK-1 inhibition disrupts Pim-2-associated and Pim-2-independent key signaling pathways to effectively suppress tumor growth and restore bone formation in myeloma,
American Society for Bone and Mineral Research 2016 Annual Meeting, Atlanta, Sep. 2016.
27. Hirofumi Tenshin, Jumpei Teramachi, A Oda, Ryota Amachi, Bingzi Dong, Masahiro Hiasa, Keiichiro Watanabe, Ryota Amachi, S Nakamura, H Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Osteoclasts utilize an apoptosis-inducer TRAIL as a stimulator for osteoclastogenesis Critical roles of the TAK-1-Pim-2 signaling induced by RANK ligand and TRAIL.,
ANZBMS 2016 Annual Meeting, Gold Coast, Aug. 2016.
28. Ken-ichi Aihara, Masashi Akaike, Sumiko Yoshida, Yasumasa Ikeda, Shusuke Yagi and Masahiro Abe :
Pleiotropic Effects of Pitavastatin against Vascular Stress in eNOS-deficient Mice,
The 10th Congress of the Asian-Pacific Society of Atherosclerosis and Vascular Diseases, Tokyo, Jul. 2016.
29. Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara :
Analysis of sodium restriction-induced blood pressure reduction in hospitalized patients with type 2 diabetes mellitus,
The 10th Congress of the Asian-Pacific Society of Atherosclerosis and Vascular Diseases, Tokyo, Jul. 2016.
30. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Therapeutic impact of TAK-1 inhibition on tumor growth and bone destruction in myeloma,
21st Congress European Hematology Association, Copenhagen, Jun. 2016.
31. Noboru Niki, Yoshiki Kawata, Hidenobu Suzuki, Mitsuo Shimada, Masafumi Harada, Issei Imoto, Masahiro Abe, Keiji Umetani, Hironobu Ohmatsu, Genichirou Ishii, Gen Iinuma, Keiji Aokage, Yuuji Matsumoto, Yasutaka Nakano, Michiaki Mishima and Hiroaki Sakai :
Cancer diagnosis and prognosis assistance based on multidisciplinary computational anatomy - Progress Overview FY2015 -,
The 2nd International Symposium on Multidisciplinary Computational Anatomy, 83-89, Feb. 2016.
32. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Derek Hanson, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Pim inhibition suppresses osteoclastogenesis and tumor growth in myeloma,
57th ASH Annual Meeting and Exposition, Orlando, Dec. 2015.
33. Hirofumi Tenshin, Jumpei Teramachi, A Oda, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, S Nakamura, H Miki, I Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAIL is not a proapoptotic but rather anti-apoptotic mediator for osteoclasts to stimulate their differentiation and survival,
ASBMR 2015 Annual Meeting, Seattle, Oct. 2015.
34. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, Asuka Oda, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shiroh Fujii, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Up-regulation of the pH sensor TRPV1 in myeloma cells and their adaption to an acidic microenvironment,
ASBMR 2015 Annual Meeting, Seattle, Oct. 2015.
35. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Pivotal role of TAK-1 in tumor growth and bone destruction in myeloma: Therapeutic impact of TAK-1 inhibition,
American Society for Bone and Mineral Research 2015 Annual Meeting, Oct. 2015.
36. Hirokazu Miki, Shingen Nakamura, Hirofumi Tenshin, Ryota Amachi, Keiichiro Watanabe, Jumpei Teramachi, Shiroh Fujii, Kumiko Kagawa and Masahiro Abe :
Effective impairment of myeloma progenitors by hyperthermia: augmentation with bortezomib and Pim inhibition in combination,
Clinical Lymphoma, Myeloma & Leukemia, Vol.15, No.S3, e217-e218, Sep. 2015.
(DOI: 10.1016/j.clml.2015.07.470)
37. Shingen Nakamura, Hirokazu Miki, Hirofumi Tenshin, Ryota Amachi, Keiichiro Watanabe, Jumpei Teramachi, Shiroh Fujii, Kumiko Kagawa and Masahiro Abe :
Alteration of Pim-2 expression by clinically available anti-myeloma agents: combinatory anti-myeloma effects with Pim inhibition,
Clinical Lymphoma, Myeloma & Leukemia, Vol.15, No.S3, e243, Sep. 2015.
(DOI: 10.1016/j.clml.2015.07.517)
38. Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara, nishi Oh Yukiyo, Bingzi Dong, Kiyoe Kurahashi, Sumiko Yoshida, Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Serum carboxy-terminal telopeptide of type I collagen, as a marker for systemic atherosclerosis,
ANZBMS 2015 Annual Meeting, Hobart, Sep. 2015.
39. Noboru Niki, Yoshiki Kawata, Hidenobu Suzuki, Mitsuo Shimada, Masafumi Harada, Issei Imoto, Masahiro Abe, Keiji Umetani, Hironobu Ohmatsu, Genichirou Ishii, Gen Iinuma, Keiju Aokage, Yuji Matsumoto, Yasutaka Nakano, Michiaki Mishima and Hiroaki Sakai :
Cancer diagnosis and prognosis assistance based on multidisciplinary computational anatomy -Plan of five years and progress overview FY2014-,
he First International Symposium on the Project ``Multidisciplinary Computational Anatomy'', 40-44, Fukuoka, Feb. 2015.
40. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Kumiko Kagawa, Hirokazu Miki, Shiroh Fujii, Keiichiro Watanabe, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Critical role of Pim-2 in NF-B-mediated suppression of osteoblastogenesis and stimulation of osteoclastogenesis: Therapeutic impact of Pim inhibition on myeloma bone disease.,
2014 ASBMR Annual Meeting, Houston, Sep. 2014.
41. Dong Bingzi, Takeshi Kondo, Itsuro Endo, 大西 幸代, 尾松 卓, Masahiro Abe, 相澤 慎一 and Toshio Matsumoto :
educed bone formation and increased adiposity with insulin resistance in interleukin-11 deficient mice,
European Calcified Tissue Society Annual Meeting 2014, Prague, May 2014.
42. Noboru Niki, Yoshiki Kawata, Hidenobu Suzuki, Masafumi Harada, Hideki Otsuka, Junji Ueno, Mitsuo Shimada, Tetsuji Takayama, Masahiro Abe, Haruimi Itoh, Kenji Eguchi, Masahiko Kusumoto, Takaaki Tsuchida, Hironobu Ohmatsu, Masashi Takahashi, Yasutaka Nakano, Hiroaki Sakai and Yuichi Takiguchi :
Computer-aided diagnosis based on computational anatomical models:Progress overview FY2009-2013,
The 5th International Symposium on the Project ``Computational Anatomy'', 39-43, Mar. 2014.
43. Ryota Amachi, Masahiro Abe, Masahiro Hiasa, Keiichiro Watanabe, S Fujii, T Harada, H Miki, S Nakamura, I Endo, Eiji Tanaka and Toshio Matsumoto :
Acidic conditions epigenetically repress the TRAIL receptor DR4 in myeloma cells to confer their resistance to TRAIL,
ASBMR 2013 Annual Meeting,, Baltimore, Oct. 2013.
44. Keiichiro Watanabe, Masahiro Abe, H Mori, Ryota Amachi, Masahiro Hiasa, T Harada, S Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
Potent induction of bone formation in myeloma bone lesions by the cathepsin K inhibitor KK1-300-01 in combination with the proteasome inhibitor bortezomib,
ASBMR 2013 Annual Meeting,, Baltimore, Oct. 2013.
45. Masahiro Abe :
Overview of the pathophysiology of MBD and acquired genetic events: Bench work for the targeted therapy to the microenvironment of MBD,
The 14th International Myeloma Workshop, Apr. 2013.
46. Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, H Mori, Itsuro Endo, Eiji Tanaka and Toshio Matsumoto :
Induction of bone formation in myeloma osteolytic lesions by cathepsinK inhibition,
Kyoto, Apr. 2013.
47. Ryota Amachi, Keiichiro Watanabe, Shiroh Fujii, T Harada, Hirokazu Miki, Shingen Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
An acidic milieu suppersses histone acetylation in myeloma cells to down-regulate the TRAIL receptor DR4 expression.,
Kyoto, Apr. 2013.
48. Noboru Niki, Yoshiki Kawata, Hidenobu Suzuki, Masafumi Harada, Hideki Otsuka, Junji Ueno, Mitsuo Shimada, Tetsuji Takayama, Masahiro Abe, Harumi Itoh, Masahiro Kaneko, Kenji Eguchi, Masahiko Kusumoto, Takaaki Tsuchida, Hironobu Ohmatsu, Masashi Takahashi, Yasutaka Nakano, Hiroaki Sakai and Yuichi Takiguchi :
Computer-Aided Diagnosis Based on Computational Anatomical Models: Progress Overview FY2012,
he 4th International Symposium on the Project ``Computational Anatomy'', 45-51, Feb. 2013.
49. Harada Takeshi, Ozaki Shuji, Oda Asuka, Iwasa Masami, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Abe, Shibata Hironobu, Akishige Ikegame, Daisuke Tsuji, Ito Kohji, Ri Masaki, Iida Shinsuke, Shiotsu Yukimasa, Kawai Shigeto, Yamada-Okabe Hisafumi and Toshio Matsumoto :
Combination therapy of a defucosylated anti-HM1.24 monoclonal antibody plus Ienalidomide induces marked antibody-dependent cellular cytotoxicity and inhibits the clonogenic potential of myeloma cancer stem-like cells. Atlanta, Dec. 2012.,
The 54th Annual Meeting of the American Society of Hamatology, Dec. 2012.
50. T Harada, Shuji Ozaki, A Oda, M Iwasa, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Abe, Hirofumi Shibata, Akishige Ikegame, Daisuke Tsuji, Kouji Itou, M Ri, S Iida, Y Shiotsu, S Kawai, H Yamada-Okabe and Toshio Matsumoto :
Combination Therapy of a Defucosylated Anti-HM1.24 Monoclonal Antibody Plus Lenalidomide Induces Marked Antibody-Dependent Cellular Cytotoxicity and Inhibits the Clonogenic Potential of Myeloma Cancer Stem-Like Cells.,
54th ASH Annual Meeting and Exposition, USA, Atlanta, Dec. 2012.
51. Ryota Amachi, Masahiro Abe, Ryota Amachi, Keiichiro Watanabe, S Fujii, T Harada, H Miki, S Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
An acidic milieu suppresses DR4 editing to cause myeloma resistance to TRAIL,
ASEAN plus and Tokushima Joint International Conference, Yogjakarta, Indonesia, Dec. 2012.
52. Masahiro Abe, Masahiro Hiasa, Watanabe ken-ichiro, Nakamura Shingen, Harada Takeshi, Itsuro Endo and Toshio Matsumoto :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition,
12th CIBD International Meeting on Cancer Induced Bone Disease (CIBD) Lyon, Nov. 2012, Nov. 2012.
53. Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Harada Takeshi, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition,
12th Int'l Meeting on Cancer Induced Bone Disease, Lyon, Nov. 2012.
54. Masahiro Hiasa, Ryota Amachi, Keiichiro Watanabe, Harada Takeshi, Fujii Shirou, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Pim-2 suppresses BMP-2 signaling as a common inhibitory mediator of osteoblastogenesis in myeloma,
ASBMR 2012 Anuual Meeting, Minneapolis, Oct. 2012.
55. Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, T Harada, S Fujii, S Nakamura, H Miki, K Kagawa, H Mori, I Endo, Eiji Tanaka and Toshio Matsumoto :
Restoration of bone formation in myeloma osteolytic lesions by the cathepsin K inhibitor KK1-300-01,
34th ASBMR meeting, Minneapolis, MN, USA., Oct. 2012.
56. Masahiro Hiasa, Masahiro Abe and Toshio Matsumoto :
RelB attenuates the activation of the classical NF-kB pathway to facilitate osteoblastogenesis,
Sep. 2012.
57. Masahiro Hiasa, Masahiro Abe, Rieko Arakaki, Akiko Yamada, Kenzo Asaoka, Toshio Matsumoto, Yoshio Hayashi and Naozumi Ishimaru :
RelB attenuates the activation of the classical NF-κB pathway to facilitate osteoblastogenesis,
ANZBMS Annual Scientific Meeting, Perth, Sep. 2012.
58. Keiichiro Watanabe, Masahiro Abe, Hiroyo Mori, Ryota Amachi, Masahiro Hiasa, T Harada, S Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
The cathepsin K inhibitor KK1-300-01 prevents bone destruction and resumes bone formation in myeloma osteolytic lesions,
Australian & New Zealand Bone & Mineral Society 22th Annual Scientific Meeting with 1st Asia-Pacific Bone and Mineral Research meeting, Perth, Australia., Sep. 2012.
59. Noboru Niki, Yoshiki Kawata, Hidenobu Suzuki, Masafumi Harada, Hideki Otsuka, Junji Ueno, Mitsuo Shimada, Tetsuji Takayama, Masahiro Abe, Harumi Itoh, Masahiro Kaneko, Kenji Eguchi, Masahiko Kusumoto, Takaaki Tsuchida, Hironobu Ohmatsu, Masashi Takahashi, Yasutaka Nakano, Hiroaki Sakai and Yuichi Takiguchi :
Computer-aided diagnosis based on computational anatomical models: progress overview FY2011,
The 3rd International Symposium on the Project ``Computational Anatomy'', 35-42, Mar. 2012.
60. Ayako Nakano and Masahiro Abe :
Inactivation of ABC transporters to restore drug sensitivity in myeloma cells by inhibition of hexokinase II,
53th Annual Meeting of the American Society of Hematology, Dec. 2011.
61. Masahiro Abe :
An Acidic Milieu Aggravates Myeloma Growth And Drug Resistance But Triggers Anti-myeloma Activity Of Reveromycin A, A Novel Anti-resorptive Agent,
11th International Meeting on Cancer Induced Bone Disease, Dec. 2011.
62. Keiichiro Watanabe, Masahiro Abe, M Kawatani, Masahiro Hiasa, A Kawano, T Jinno, T Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, H Osada and Toshio Matsumoto :
Aggravation of myeloma growth and drug resistance by an acidic created in myeloma-osteoclast interaction.,
ASBMR 2011 Annual Meeting, San Diego, Sep. 2011.
63. Masahiro Hiasa, nakano ayako, Keiichiro Watanabe, C Qu, T Harada, Shiroh Fujii, Hirokazu Miki, Shingen Nakamura, Kumiko Kagawa, Kyoko Takeuchi, Eiji Tanaka, Kenzo Asaoka, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition.,
ASBMR 2011 Annual Meeting, San Diego, Sep. 2011.
64. Masahiro Hiasa, nakano ayako, Keiichiro Watanabe, C Qu, T Harada, Shiroh Fujii, Hirokazu Miki, Shingen Nakamura, Kumiko Kagawa, Kyoko Takeuchi, Eiji Tanaka, Kenzo Asaoka, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Dual effects of Pim inhibition on myeloma: induction of bone formation and tumor suppression.,
IOF-ANZBMS 2011 Annual Meeting, Gold Coast, Sep. 2011.
65. Masahiro Abe :
An acidic microenvironment enhances myeloma growth but triggers anti-tumor and anti-resorptive activity of reveromycin A,
European Congress on Osteoporosis & Osteoarthritis ECCEO11-IOF, Mar. 2011.
66. Noboru Niki, Yoshiki Kawata, Hidenobu Suzuki, Masafumi Harada, Hideki Otsuka, Junji Ueno, Mitsuo Shimada, Tetsuji Takayama, Masahiro Abe, Harumi Itoh, Masahiro Kaneko, kenji Eguchi, Masahiko Kusumoto, Takaaki Tsuchida, Hironobu Ohmatsu, Masashi Takahashi, Yasutaka Nakano and Hiroaki Sakai :
Computer-aided diagnosis based on computational anatomical models: progress overview FY2010,
The 2nd International Symposium on the Project ``Computational Anatomy'', 95-100, Mar. 2011.
67. Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
An Acidic Mileu Created In Myeloma-Osteoclast Interaction Enhances Tumor Growth, but Triggers Anti-Myeloma Activity of Reveromycin A, a Novel Anti-Resorptive Agent,
52th American Society of Hematology, Orlando, Dec. 2010.
68. Cui Qu, Masahiro Abe, Miki Hirokazu, Shingen Nakamura, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, Nakano Ayako, Harada Takeshi, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
Lenalidomide In Combination with Zoledronic Acid Restores the Activation and Anti-Myeloma Effects of γδT Cells Attenuated by the Bone Marrow Microenvironment,
52th American Society of Hematology, Orlando, Dec. 2010.
69. Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
A Novel Anti-resorptive Agent, Reveromycin A, Ameliorates Bone Destruction and Tumor Growth in Myeloma,
ASBMR 2010 Annual Meeting, Toronto, Oct. 2010.
70. Masahiro Hiasa, Masahiro Abe, nakano ayako, oda aska, amo hiroe, Keiichiro Watanabe, Shingen Nakamura, miki hirokazu, Kyoko Takeuchi, Kumiko Kagawa, Shuji Ozaki, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Bone Marrow Stromal Cells Suppress TACE-mediated M-CSFR and RANK Shedding to Facilitate Osteoclastogenesis and Suppress DC Differentiation from Monocytes.,
ASBMR 2010 Annual Meeting, Toronto, Oct. 2010.
71. Masahiro Abe, Masahiro Hiasa, Nakano A, Shingen Nakamura, Miki H, Qu C, Keiichiro Watanabe, Harada T, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
TIMP-3 up-regulation facilitates osteoclastogenesis and suppresses DC differentiation from monocytes in the bone marrow microenvironment in myeloma,
10th International Conference Cancer-induced Bone Disease, Sep. 2010.
72. Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
The novel anti-resorptive agent reveromycin A ameliorates bone destruction and tumor growth in myeloma,
10th International Conference Cancer-induced Bone Disease, Sheffield (United Kingdom), Sep. 2010.
73. Masahiro Hiasa, Masahiro Abe, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Stroma inhibit DC differentiation through the suppression of M-CSFR shedding,
88th IADR, Barcelona, Jul. 2010.
74. Masahiro Hiasa, Masahiro Abe, I Endo, A Nakano, Shuji Ozaki, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Myeloma-bone marrow stromal cell interaction enhances osteoclastogenesis and suppresses dendritic cell differentiation from monocytes,
14th International Congress of Endocrinology, Kyoto, Mar. 2010.
75. Noboru Niki, Yoshiki Kawata, Hiromu Nishitani, Mitsuo Shimada, Junji Ueno, Masafumi Harada, Masahiro Abe, Hideki Otsuka, Harumi Itoh, Masahiro Kaneko, Takaaki Tuchida, Kenji Eguchi, Hironobu Ohmatsu, Masashi Takahashi and Yasutaka Nakano :
Computer-aided diagnosis based on computational anatomical models,
The First International Symposium on the Project ``Computational Anatomy'', 65-71, Tokyo, Feb. 2010.
76. Akishige Ikegame, Shuji Ozaki, Daisuke Tsuji, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Ayako Nakano, Kumiko Kagawa, Kyoko Takeuchi, Ken-ichiro Yata, Masahiro Abe, Kouji Itou and Toshio Matsumoto :
A recombinant HLA class I-specifi single-chain Fv diabody can target cancer stem cell-like side population cells in multiple myeloma,
51th Annual Meeting of the American Society of Hematolog, New Orleans, Louisiana, USA, Dec. 2009.
77. Masahiro Hiasa, Masahiro Abe, A Nakano, Kyoko Takeuchi, K Watanabe, Kumiko Kagawa, Ken-ichiro Yata, Kenzo Asaoka, Eiji Tanaka and Toshio Matsumoto :
Bone marrow stromal cells inhibit dendritic cell differentiation and facilitate osteoclastogenesis in myeloma through the suppression of M-CSF receptor shedding in monocytes,
第26回 内藤コンファレンス, Nov. 2009.
78. S Nakamura, Masahiro Abe, Cui Qui, A Nakano, Oda A., Amou H., Ikegame A., Harada T., Masahiro Hiasa, H Miki, Kumiko Kagawa, Kyoko Takeuchi, Ken-ichiro Yata, Shuji Ozaki and Toshio Matsumoto :
Facilitation of Osteoblast Differentiation by ATF-4 Accumulation through Proteasome Inhibition.,
ASH Annual Meeting, Nov. 2009.
79. Itsuro Endo, Onishi Yukiyo, Kido Rika, Kurahashi Kiyoe, Ito Yuuji, Yuichi Fujinaka, Ken-ichi Aihara, Sumiko Yoshida, Masahiro Abe, Fukumoto S and Toshio Matsumoto :
A new calcilytic compound,JTT-305,inhibits enhanced signaling by activating mutations of calcium-sensing receptor in autosomal dominant hypocalcemia (ADH),
ASBMR 31st Annual Meeting, Denver, Sep. 2009.
80. A Nakano, Asano J., Masahiro Abe, Masahiro Hiasa, S Nakamura, H Miki, Kumiko Kagawa, Kyoko Takeuchi, Ken-ichiro Yata, Itsuro Endo, Shuji Ozaki and Toshio Matsumoto :
Up-regulation of Pim-2 in myeloma cells by an interaction with bone marrow microenvironment enhances myeloma cell survival via stimulating Bad phosphorylation,
ASBMR Annual Meeting, Denver, Sep. 2009.
81. Masahiro Abe, A Oda, Shinsuke Kido, A Nakano, Masahiro Hiasa, H Amou, S Nakamura, Kyoko Takeuchi, H Miki, Kumiko Kagawa, Ken-ichiro Yata, Shuji Ozaki, Itsuro Endo and Toshio Matsumoto :
Bortezomib, a proteasome inhibitor with anti-myeloma activity, stimulates osteoblast differentiation by enhancing ATF4 accumulation in osteoblastic cells.,
ASBMR Annual Meeting, Denver, Sep. 2009.
82. Ken-ichiro Yata, Masahiro Abe, Oda A., Amou H., takeuchi K., Masahiro Hiasa, Nakano A., Miki H., Nakamura S., Tanaka O., Kumiko Kagawa, Shuji Ozaki and Toshio Matsumoto :
Anti-myeloma effects of γδ T cells are hampered by bone marrow stromal cells but resumed by stromal cell-derived osteoblasts,
Annual Meeting of the American Society of Hematology, San Francisco, Dec. 2008.
83. Takashi Iwase, Hirotsugu Kurobe, Masashi Akaike, Shunji Nakano, Sumiko Yoshida, Sumitomo Yuka, Shusuke Yagi, Ken-ichi Aihara, Shuji Ozaki, Masahiro Abe, Natsuo Yasui, Toshio Matsumoto, Tetsuya Kitagawa and Masataka Sata :
Erythropoietin administration with autologous blood donation - a novel strategy to enhance mobilization of circulating progenitor cells,
American Heart Association Sessions 2008, New Orleans, Nov. 2008.
84. Masahiro Abe, Masahiro Hiasa, Oda A., Amou H., takeuchi K., Tanaka O., Nakamura S., Miki H., Kumiko Kagawa, Ken-ichiro Yata, Shuji Ozaki, Kido S. and Toshio Matsumoto :
Bone marrow stromal cells up-regulate M-CSF receptor in monocytes to disrupt dendritic cell differentiation while facilitating osteoclastogenesis in myeloma,
ASBMR, Montreal, Sep. 2008.
85. Takeuchi K., Masahiro Abe, Oda A., Amou H., Masahiro Hiasa, Tanaka O., Nakamura S., Miki H., Kumiko Kagawa, Ken-ichiro Yata, Hashimoto T., Shuji Ozaki, Kido S. and Toshio Matsumoto :
TGF-β Suppresses Adipocytic Differentiation and Enhances Accumulation of Stromal Cells in Myeloma Bone Lesions,
ASBMR, Montreal, Sep. 2008.
86. Masahiro Abe, Masahiro Hiasa, Kido S., Oda A., Amou H., takeuchi K., Ken-ichiro Yata, Shuji Ozaki and Toshio Matsumoto :
TACE up-regulation in monocytes by GM-CSF and IL-4 disrupts myeloma cell-induced osteoclastogenesis while inducing dendritic cell differentiation,
International Meeting on Cancer Induced Bone Disease, Scotland, Jun. 2008.
87. Takako Miyamoto, Shinsuke Kido, Masahiro Abe, Toshio Matsumoto and Hisaaki Taniguchi :
Expression Profiling by Quantitative and Large-scale Proteomics in Differentiating Osteoblasts,
HUPO 5th Annual World Congress, Los Angeles, Nov. 2006.
88. Ali Jalili, Shuji Ozaki, Tomoko Hara, Etsuko Sekimoto, Yoichi Tanaka, Takashi Ohshima, Hironobu Shibata, Toshihiro Hashimoto, Masahiro Abe, Yasuhiko Nishioka and Toshio Matsumoto :
Generation of HM1.24-specific cytotoxic T lymphocytes from peripheral blood stem cell harvests of patients with multiple myeloma,
46th Annual Meeting: American Society of Hematology, San Francisco, Dec. 2004.
89. Atsushi Shioyasono, Yasuo Oba, Hiura Kenji, Masahiro Abe, Toshio Matsumoto and Keiji Moriyama :
MIP-1alpha is upregulated during experimental tooth movement,
IADR 82nd General Session, Honolulu, Mar. 2004.

Proceeding of Domestic Conference:

1. Masahiro Hiasa, Masahiro Abe, 中野 綾子, Keiichiro Watanabe, Shingen Nakamura, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 178,
2. Keiichiro Watanabe, Masahiro Abe, 川谷 誠, Masahiro Hiasa, Shingen Nakamura, Eiji Tanaka, 長田 裕之 and Toshio Matsumoto :
リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の抑制,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 208,
3. Sumiko Yoshida, Ken-ichi Aihara and Masahiro Abe :
エイコサペントエン酸は酸化ストレス抑制を介してアンジオテンシンII刺激による心血管リモデリングを抑制する,
第37回内分泌代謝学サマーセミナー, Jul. 2019.
4. Sumiko Yoshida, Ken-ichi Aihara and Masahiro Abe :
心血管病と性差 ∼アンドロゲンを中心に∼,
第61回日本老年医学会学術集会, Jun. 2019.
5. 宮高 絋輔, Sumiko Yoshida, Furi Endo, 枡田 志保, 三井 由加里, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Makoto Funaki, Yoshihiro Matsudate, Hiroshi Nokihara, Yasuhiko Nishioka, Masahiro Abe and Munehide Matsuhisa :
免疫チェックポイント阻害薬投与後に1型糖尿病を発症した2例,
第62回日本糖尿病学会年次学術集会, May 2019.
6. Mai Kanai, 松岡 飛翔, Itsuro Endo, 大西 幸代, Yuichi Takashi, Kiyoe Kurahashi, Sumiko Yoshida, Ken-ichi Aihara, Masahiro Abe, Seiji Fukumoto and Toshio Matsumoto :
鉄製剤投与によるFGF23関連低リン血症モデル作成の試み,
日本内分泌学会雑誌, Vol.95, No.1, 422, May 2019.
7. Yuichi Takashi, Hidetaka Kosako, Shun Sawatsubashi, Yuka Kinoshita, 伊東 伸朗, Masahiro Abe, Munehide Matsuhisa, Shigeaki Kato, Toshio Matsumoto and Seiji Fukumoto :
FGFR1はFGF23濃度調節を媒介するリン感知受容体である,
日本内分泌学会雑誌, Vol.95, No.1, 333, May 2019.
8. Sumiko Yoshida, Ken-ichi Aihara and Masahiro Abe :
骨格筋アンドロゲン受容体と耐糖能異常の検討,
第92回日本内分泌学会総会, May 2019.
9. Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa and Masahiro Abe :
TAK1阻害は腫瘍と微小環境との相互作用を遮断し腫瘍進展・骨破壊病変形成を抑 制する,
第124回日本解剖学会総会・全国学術集会, Mar. 2019.
10. Yuto Tanigaki, Yuta Yamaguchi, Naoto Okada, Shingen Nakamura, Kumiko Kagawa, Shiroh Fujii, Hirokazu Miki, Keisuke Ishizawa, Masahiro Abe and Youichi Sato :
ゲノムワイド関連解析を用いたテイコプラニン・バンコマイシン投与による皮疹発現および血中濃度関連遺伝子座の同定,
日本薬学会 第139年会, Mar. 2019.
11. Kohsuke Miyataka, Furi Endo, 三井 由加里, 枡田 志保, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Hiroshi Nokihara, Yasuhiko Nishioka, Masahiro Abe and Munehide Matsuhisa :
抗PD-1抗体投与後に1型糖尿病を発症した1例,
第258回徳島医学会学術集会 ポスターセッション, Feb. 2019.
12. Yohsuke Kaneko, Mayo Kondou, Naoki Takahashi, Makoto Tobiume, Hirokazu Ogino, Seidai Satou, Hirokazu Miki, Hisatsugu Goto, Masahiro Abe and Yasuhiko Nishioka :
多発小結節影を認めたHIV陽性ニューモシスチス肺炎の1例,
第119回日本内科学会四国地方会, Dec. 2018.
13. Rio Ohmori, Naoto Okada, Shingen Nakamura, Kumiko Kagawa, Shiroh Fujii, Hirokazu Miki, Keisuke Ishizawa, Masahiro Abe and Youichi Sato :
ゲノムワイド関連解析を用いたビンクリスチンによる末梢神経障害発現関連遺伝子の同定,
第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2018.
14. Yuta Yamaguchi, Yuto Tanigaki, Naoto Okada, Shingen Nakamura, Kumiko Kagawa, Shiroh Fujii, Hirokazu Miki, Keisuke Ishizawa, Masahiro Abe and Youichi Sato :
CYP遺伝子多型とバンコマイシンの副作用発現及び血中濃度との関連解析,
第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2018.
15. Sumiko Yoshida, 原 倫世, 山口 佑樹, Takeshi Kondo, 遠藤 ふうり, 筒井 康継, 桝田 志保, Kiyoe Kurahashi, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe, Kohhei Nakajima and Seiji Fukumoto :
急速に腫瘍が増大し悪性転化が疑われたCushing病の1例,
第28回臨床内分泌代謝Update, Nov. 2018.
16. 鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, Mizuho Kinouchi, Kimiko Sogabe, 加部 一行, 瀬尾 浩二, Masaharu Nishi, Naoya Matsumoto, Yasuhiko Kanagawa, Masahiro Abe, Toshio Matsumoto, 寺澤 敏秀 and Munehide Matsuhisa :
リブレ使用糖尿病患者の検討,
日本糖尿病学会中国四国地方会第56回総会, Oct. 2018.
17. Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Oda Asuka, Bat-Erdene Ariunzaya, Takeshi Harada, Iwasa Masami, Shiroh Fujii, Kimiko Sogabe, Shingen Nakamura, Hirokazu Miki, Masahiro Oura, Kumiko Kagawa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Mechanisms of TAK1 over-activation in myeloma cells and TAK1-mediated myeloma growth and bone destruction,
第80回日本血液学会学術集会, Oct. 2018.
18. Masami Iwasa, Takeshi Harada, Bat-Erdene Ariunzaya, 小田 明日香, Kimiko Sogabe, Masahiro Oura, Jumpei Teramachi, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa and Masahiro Abe :
HDAC阻害による骨髄腫細胞のIFN-γ-STAT1- PD-L1経路の増強効果,
第80回日本血液学会学術集会, Oct. 2018.
19. Ashtar Mohannad, Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Kotaro Tanimoto, Oda Asuka, Iwasa Masami, Takeshi Harada, Ariunzaya Erdene Bat, Kimiko Sogabe, Oura Masahiro, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Roles of ROS in induction of bone disease and cancer treatment-induced bone loss in myeloma.,
The 80th Annual Meeting of the Japanese Society of Hematology, Oct. 2018.
20. Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Kotaro Tanimoto, Mohannad Ashtar, Ariunzaya Bat-Erdene, Iwasa Masami, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Kimiko Sogabe, Oura Masahiro, Shiroh Fujii, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Inverse regulation of c-FLIP-mediated survival in myeloma cells and osteoclasts by TRAIL.,
The 80th Annual Meeting of the Japanese Society of Hematology, Oct. 2018.
21. Kotaro Tanimoto, Masahiro Hiasa, Hirofumi Tenshin, Jumpei Teramachi, Oda Asuka, Mohannad Ashtar, Ariunzaya Bat-Erdene, Iwasa Masami, Kimiko Sogabe, Oura Masahiro, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Impact of denervation-induced paralysis and mechanical unloading on tumor expansion in myeloma.,
The 80th Annual Meeting of the Japanese Society of Hematology, Oct. 2018.
22. Masahiro Hiasa, Jumpei Teramachi, Hirofumi Tenshin, Kotaro Tanimoto, Ariunzaya Bat-Erdene, Mohannad Ashtar, Masami Iwasa, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Kimiko Sogabe, Oura Masahiro, Shiroh Fujii, Kumiko Kagawa, Oda Asuka, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
The effects of cathepsin K inhibition on osteocytes: its role in bone restoration in MM bone disease.,
The 80th Annual Meeting of the Japanese Society of Hematology, Oct. 2018.
23. Mariko Ikuo, Kei Sugisaki, Jumpei Teramachi, 田原 栄俊, Masahiro Abe and Kouji Itou :
骨芽前駆細胞の骨分化経路BMP/Smadは,核内DNA結合Smadを標的とする多発性骨髄腫由来分泌小胞exosomeによって抑制される,
第91回日本生化学会大会, Sep. 2018.
24. Kiyoe Kurahashi, Itsuro Endo, Takeshi Kondo, 遠藤 ふうり, 原 倫世, 桝田 志保, Sumiko Yoshida, 明比 祐子, Yoshimi Bando, Ken-ichi Aihara, Masahiro Abe and Seiji Fukumoto :
ソマトスタチンアナログ製剤にて著明な縮小がみられたGH産生マクロアデノーマの1例,
第22回 日本臨床内分泌病理学会, Sep. 2018.
25. 原 倫世, Sumiko Yoshida, 細井 美希, 遠藤 ふうり, 筒井 康継, 桝田 志保, Kiyoe Kurahashi, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Kohhei Nakajima, Yoshimi Bando, Masahiro Abe and Seiji Fukumoto :
脳内,副鼻腔,下垂体に炎症を認めステロイドが著効した1例,
第22回日本臨床内分泌病理学会, Sep. 2018.
26. Ken-ichi Aihara, Sumiko Yoshida, Furi Endo, 筒井 康継, Tomoyo Hara, 桝田 志保, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Itsuro Endo, Kana Morimoto, Akio Kuroda, 明比 祐子, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe :
原発性アルドステロン症におけるミネラルコルチコイド受容体拮抗薬の血管機能への影響,
第18回日本内分泌学会四国支部学術集会, Sep. 2018.
27. 山上 紘規, Sumiko Yoshida, 遠藤 ふうり, 原 倫世, 筒井 康継, 桝田 志保, Kiyoe Kurahashi, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Yusuke Osaki, Ryuji Kaji, Yuichi Takashi, Masahiro Abe and Seiji Fukumoto :
壊死性ミオパチーを合併したX連鎖性低リン血症性くる病・骨軟化症の一例,
第18回日本内分泌学会四国支部学術集会, Sep. 2018.
28. Itsuro Endo, 大西 幸代, Kiyoe Kurahashi, Jumpei Teramachi, Masahiro Hiasa, Hirofumi Tenshin, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
カルシウム感知受容体活性型変異マウスにおける骨強度の低下,
第36回日本骨粗鬆症学会各術集会, Jul. 2018.
29. Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
TAK1 inhibition impairs myeloma cell-bone marrow interaction to reduce myeloma growth and bone destruction,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, Jul. 2018.
30. Masahiro Hiasa, Jumpei Teramachi, Hirofumi Tenshin, Kotaro Tanimoto, Mohannad Ashtar, Ariunzaya Bat-Erdene, Masami Iwasa, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
カテプシンK阻害による多発性骨髄腫骨病変部の骨量 回復プロセスにおける骨細胞の役割.,
第36回日本骨代謝学会学術集会, Jul. 2018.
31. Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, Kotaro Tanimoto, Mohannad Ashtar, Ariunzaya Bat-Erdene, Masami Iwasa, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1阻害はTRAILによる破骨細胞活性化作用を遮断 させると同時にTRAILの抗骨髄腫作用を増強する,
第36回日本骨代謝学会学術集会, Jul. 2018.
32. Hirofumi Tenshin, Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Kotaro Tanimoto, Mohannad Ashtar, Ariunzaya Bat-Erdene, Masami Iwasa, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1による破骨細胞に対するTRAILの生存・細胞死シグナル制御機構.,
第4回日本骨免疫学会, Jun. 2018.
33. Kotaro Tanimoto, Masahiro Hiasa, Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Mohannad Ashtar, Ariunzaya Bat-Erdene, Masami Iwasa, Kimiko Sogabe, 大浦 雅弘, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
神経切断による麻痺と免荷の骨髄腫の進展への影響.,
第4回日本骨免疫学会, Jun. 2018.
34. Sumiko Yoshida, 原 倫世, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe and Munehide Matsuhisa :
高齢者における糖尿病教育入院中の体組成の変化,
第60回日本老年医学会学術集会, Jun. 2018.
35. Akio Kuroda, Misuzu Yamada, 冨永 ゆかり, 鈴木 麗子, Motoyuki Tamaki, 明比 祐子, Yuichi Takashi, Masashi Ishizu, 古賀 大輔, Issei Imoto, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe, Kevin Ferreri and Munehide Matsuhisa :
膵β細胞特異的PCRによる膵β細胞死の検出,
第61回日本糖尿病学会年次学術集会, May 2018.
36. Sumiko Yoshida, 原 倫世, 細井 美希, 山上 紘規, 山口 佑樹, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa :
糖尿病教育入院における筋肉量の変化,
第61回日本糖尿病学会年次学術集会, May 2018.
37. 山上 紘規, Sumiko Yoshida, 原 倫世, 細井 美希, 山口 佑樹, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Masahiro Abe, Yoshihiro Matsudate and Munehide Matsuhisa :
免疫チェックポイント阻害薬投与後に甲状腺機能異常と劇症1型糖尿病を発症した1例,
第61回日本糖尿病学会年次学術集会, May 2018.
38. Ken-ichi Aihara, 上元 良子, 石川 カズ江, Kana Morimoto, 桝田 志保, Hiroki Yamagami, Yuki Yamaguchi, Tomoyo Hara, 細井 美希, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa, Hiroyuki Azuma and Masahiro Abe :
生活習慣病患者の尿中酸化ストレス指標における糖尿病および薬物療法の影響,
第61回日本糖尿病学会年次学術集会, May 2018.
39. Masami Iwasa, Takeshi Harada, Bat-Erdene Ariunzaya, 小田 明日香, 前田 悠作, 高橋 真美子, Masahiro Oura, Jumpei Teramachi, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa and Masahiro Abe :
Amplification of the IFN- γ -STAT1- PD-L1 pathway in myeloma cells by panobinostat,
The 43rd Annual Meeting of the Japanese Society of Myeloma, May 2018.
40. Takeshi Harada, Oda Asuka, Jumpei Teramachi, Bat-Erdene Ariunzaya, Iwasa Masami, Maeda Yusaku, Shingen Nakamura, Oura Masahiro, Shiroh Fujii, Hirokazu Miki, Kumiko Kagawa, Hideshima Teru, Anderson C. Kenneth and Masahiro Abe :
HDAC1/3 inhibition disrupts the IRF4-Pim-2 pathway to induce effective myeloma cell death,
The 43rd Annual Meeting of the Japanese Society of Myeloma, May 2018.
41. Itsuro Endo, Dong Bingzi, Ohnishi Yukiyo, Sumiko Yoshida, Ken-ichi Aihara, 相澤 慎一, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
常染色体優性低Ca血症1型モデルマウスにおける骨強度の低下,
第91回日本内分泌学会学術総会, Apr. 2018.
42. Sumiko Yoshida, 原 倫世, 細井 美希, 山上 紘規, 山口 佑樹, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Daisuke Hamada, Munehide Matsuhisa and Masahiro Abe :
待機的高リスク整形外科手術における血糖管理の効果,
第91回日本内分泌学会学術総会, Apr. 2018.
43. 原 倫世, 桝田 志保, Sumiko Yoshida, 細井 美希, 山上 紘規, 山口 佑樹, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe :
急性合併症を来した高齢1型糖尿病の2症例,
第29回 日本老年医学会四国地方会, Feb. 2018.
44. 斎村 玉緒, 鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, 加部 一行, Mizuho Kinouchi, Sumiko Yoshida, Hiroki Yamagami, Takeshi Kondo, 西 正晴, 松本 直也, Toshio Matsumoto, Masahiro Abe, 寺澤 敏秀 and Munehide Matsuhisa :
フラッシュグルコースモニタリングシステムにより施設入所可能となった高齢1型糖尿病の一例,
日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
45. Yuki Yamaguchi, Sumiko Yoshida, Tomoyo Hara, 細井 美希, Hiroki Yamagami, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, 福本 誠ニ, Masahiro Abe, Hideya Kashihara, Kouzou Yoshikawa and Munehide Matsuhisa :
高度肥満症に対するスリーブ状胃切除術の長期の耐糖能異常改善効果の検討,
日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
46. Naoto Kunikata, Sumiko Yoshida, Tomoyo Hara, 細井 美希, Hiroki Yamagami, Yuki Yamaguchi, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, 福本 誠ニ, Masahiro Abe, Daisuke Hamada and Munehide Matsuhisa :
待機的整形外科手術の術後経過における糖尿病の影響,
日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
47. 鶴尾 美穂, Toshio Matsumoto, Akio Kuroda, Tomoyuki Yuasa, 加部 一行, Takeshi Kondo, Mizuho Kinouchi, 井野口 卓, Hiroki Yamagami, 松本 直也, 西 正晴, 寺澤 敏秀, Masahiro Abe and Munehide Matsuhisa :
SLADHを発症した高齢1型糖尿病の一例,
日本糖尿病学会中国四国地方会第55回総会抄録集, Nov. 2017.
48. Yuto Tanigaki, Youichi Sato, Yuta Yamaguchi, Naoto Okada, Shingen Nakamura, Kumiko Kagawa, Shiroh Fujii, Hirokazu Miki, Keisuke Ishizawa, Masahiro Abe and Aiko Yamauchi :
テイコプラニン投与による副作用発現および血中濃度とCYP遺伝子多型との関連解析,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
49. Hozumi Tashima, Youichi Sato, Naoto Okada, Shingen Nakamura, Kumiko Kagawa, Shiroh Fujii, Hirokazu Miki, Keisuke Ishizawa, Masahiro Abe and Aiko Yamauchi :
シタラビン投与による副作用発現と代謝経路関連遺伝子多型の関連解析,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
50. Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Masami Iwasa, Masahiro Oura, Yusaku Maeda, Shiroh Fujii, Kumiko Kagawa, Hirokazu Miki, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Disruption of myeloma cell-bone marrow interaction by TAK-1 inhibition,
第80回日本血液学会学術集会, Oct. 2017.
51. Jumpei Teramachi, Masahiro Hiasa, Oda Asuka, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Masami Iwasa, Masahiro Ohhra, Yusaku Maeda, Shiroh Fujii, Kumiko Kagawa, Hirokazu Miki, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Disruption of myeloma cell-bone marrow interaction by TAK-1 inhibition,
第80回日本血液学会学術集会, Oct. 2017.
52. Tomoyo Hara, Sumiko Yoshida, Yuki Yamaguchi, 細井 美希, Hiroki Yamagami, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki, 福本 誠ニ and Masahiro Abe :
当院での免疫チェックポイント阻害薬による下垂体機能低下症の5例,
第17回日本内分泌学会四国支部学術集会抄録集, Sep. 2017.
53. Kyoko Nishi, Masahiro Abe, Kumiko Tanaka, Takeshi Nishino and Takeshi Tobiume :
徳島大学病院の多職種連携による若手教育ー院内ネットワーク研修を地域包括ケアシステムにおける医療従事者の確保・養成につなぐー,
第1回徳島県地域包括ケアシステム学会, Aug. 2017.
54. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Ariunzaya Baterdene, Masami Iwasa, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAILは破骨細胞を活性化させるが,TAK1阻害により骨髄腫細胞とともに破骨細胞にもTRAILのアポトーシス誘導活性が惹起できる,
The 35th Annual Meeting of the Japanese Society for Bone and Mineral Research (oral talk), Jul. 2017.
55. Sumiko Yoshida, Ken-ichi Aihara, Kiyoe Kurahashi, Itsuro Endo and Masahiro Abe :
骨格筋のアンドロゲン受容体と耐糖能異常,
第35回内分泌代謝学サマーセミナー, Jul. 2017.
56. Rio Ohmori, Youichi Sato, Misaki Kiguchi, Naoto Okada, Shingen Nakamura, Kumiko Kagawa, Shiroh Fujii, Hirokazu Miki, Keisuke Ishizawa, Masahiro Abe and Aiko Yamauchi :
ビンクリスチンによる副作用発現とMDR1遺伝子多型との関連性,
第20回日本医薬品情報学会総会・学術大会, Jul. 2017.
57. Yuta Yamaguchi, Youichi Sato, Yuto Tanigaki, Naoto Okada, Shingen Nakamura, Kumiko Kagawa, Shiroh Fujii, Hirokazu Miki, Keisuke Ishizawa, Masahiro Abe and Aiko Yamauchi :
バンコマイシン投与による副作用発現及び血中濃度とCYP遺伝子多型との関連解析,
第20回日本医薬品情報学会総会・学術大会, Jul. 2017.
58. Kana Morimoto, 桝田 志保, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Seiji Fukumoto, Munehide Matsuhisa, Masahiro Abe, Hiroyuki Azuma and Ken-ichi Aihara :
生活習慣病患者における血管内皮機能制御に関わる臨床指標の検討,
第49回日本動脈硬化学会総会・学術集会, Jul. 2017.
59. 悦子 李, 瀧本 朋美, Naoki Oda, Erika Niki, 伊藤 正一, 荻山 佳子, Ken-ichi Suga, Ryuji Nakagawa, Hirokazu Miki and Masahiro Abe :
抗Jra保有妊婦に重症胎児貧血を認め,児のJra抗原発現抑制が疑われた1症例,
第65回日本輸血細胞治療学会総会, Jun. 2017.
60. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Baterdene Ariunzaya, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1阻害はTRAILの抗骨髄腫作用を増強するともに骨吸収促進活性を抑制活性に変換する.,
第42回日本骨髄腫学会, May 2017.
61. 西山 美月, Kiyoe Kurahashi, 桝田 志保, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, 小松 まち子, Seiji Fukumoto and Masahiro Abe :
維持透析中に管理困難な高Ca血症を契機に診断されたサルコイドーシスの一例,
第116回日本内科学会四国地方会, May 2017.
62. Kana Morimoto, 桝田 志保, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, 福本 誠ニ, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara :
糖尿病患者における自律神経機能をアルブミン尿の相互関連および各病態に影響を及ぼす因子解析,
第60回日本糖尿病学会年次学術集会, May 2017.
63. Sumiko Yoshida, Ken-ichi Aihara, Kiyoe Kurahashi, Takeshi Kondo, Itsuro Endo, Tomoyuki Yuasa, Seiji Fukumoto and Masahiro Abe :
骨格筋におけるアンドロゲン受容体の耐糖能への影響,
第90回日本内分泌学会学術総会, Apr. 2017.
64. Kana Morimoto, Yuka Takahashi, Saori Yamashita, 上元 良子, 石川 カズ江, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Akio Kuroda, Itsuro Endo, Tomoyuki Yuasa, Munehide Matsuhisa, 東 博之, Masahiro Abe and Ken-ichi Aihara :
生活習慣病患者の血管内皮機能に関わる因子の臨床的検討,
第90回日本内分泌学会学術集会抄録集, Apr. 2017.
65. Jumpei Teramachi, Masahiro Hiasa, Hirofumi Tenshin, Hirohiko Okamura, Masahiro Abe and Tatsuji Haneji :
骨髄腫腫瘍進展と骨破壊病変形成におけるTAK-1の枢軸的役割,
第122回日本解剖学会総会・全国学術集会, Mar. 2017.
66. 桝田 志保, Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Itsuro Endo, Masahiro Abe, Akio Kuroda, Munehide Matsuhisa, Ken-ichi Aihara and Seiji Fukumoto :
メーグルコシダーゼ阻害薬による腸管気腫症の一例,
第115回日本内科学会四国地方会, Nov. 2016.
67. 上田 浩之, Itsuro Endo, Takeshi Kondo, Kiyoe Kurahashi, Sumiko Yoshida, Masahiro Abe, Akio Kuroda, Munehide Matsuhisa, Ken-ichi Aihara and Seiji Fukumoto :
デノスマブによる耐糖能改善,
第115回日本内科学会四国地方会, Nov. 2016.
68. Takeshi Kondo, Itsuro Endo, 明比 祐子, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto :
免疫チェックポイント阻害剤で中枢性副腎不全を来した2例,
第26回臨床内分泌代謝Update, Nov. 2016.
69. 山下 沙織, Sumiko Yoshida, 高橋 優花, Ken-ichi Aihara, Kiyoe Kurahashi, Takeshi Kondo, Kana Morimoto, Motoyuki Tamaki, Tomoyuki Yuasa, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe :
糖尿病教育入院における酸化ストレス減少に影響を及ぼす因子の検討,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
70. 鶴尾 美穂, Akio Kuroda, Tomoyuki Yuasa, Takeshi Kondo, Mizuho Kinouchi, Naoko Matsui, 細井 恵美子, Masahiro Abe, Toshio Matsumoto, Munehide Matsuhisa and 寺澤 敏秀 :
γグロブリン療養後に一過性のGAD抗体価上昇がみられた糖尿病の一例,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
71. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
30. 天真寛文, 寺町順平, 小田明日香, 天知良太, , ,破骨細胞系細胞はアポトーシス誘引因子TRAILを生存促進・破骨細胞形成誘導因子として利用する:TAK1-Pim-2経路の役割,
第19回日本癌と骨病変研究会, Nov. 2016.
72. 斎村 玉緒, 鶴尾 美穂, Akio Kuroda, Takeshi Kondo, Tomoyuki Yuasa, Mizuho Kinouchi, Masahiro Abe, Toshio Matsumoto, 寺澤 敏秀 and Munehide Matsuhisa :
インスリンポンプの院内検定の試み,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
73. 荒瀬 美晴, Takeshi Kondo, Akio Kuroda, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa :
術前後で持続血糖モニター(CGM)を比較したアドレナリン優位褐色細胞腫の二例,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
74. 上田 浩之, Takeshi Kondo, Akio Kuroda, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa :
基礎インスリンが不要であった膵性糖尿病の一例,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
75. Kana Morimoto, 桝田 志保, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara :
糖尿病患者における心電図R-R間隔変動係数に影響を及ぼす因子の検討,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
76. Masahiro Hiasa, Ryota Amachi, Hirofumi Tenshin, Shinya Horiuchi, Masahiro Abe, Naozumi Ishimaru and Eiji Tanaka :
RelBは古典的NF-κB経路の活性化を阻害し骨癒合不全と偽関節形成を予防する,
日本矯正歯科学会大会プログラム・抄録集., 192., Nov. 2016.
77. Jumpei Teramachi, Masahiro Hiasa, Hirohiko Okamura, Masahiro Abe and Tatsuji Haneji :
骨髄腫の腫瘍進展と骨破壊病変形成におけるTAK1の枢軸的な役割,
日本解剖学会第71回中国・四国支部学術集会, Oct. 2016.
78. Jumpei Teramachi, Hiroshi Mori, Yasuo Ochi, Ryota Amachi, Asuka Oda, Masahiro Hiasa, Takeshi Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Potent induction of bone formation by anti-resorptive cathepsin K inhibitor in myeloma.,
The 77th Annual Meeting of the Japanese Society of Hematology, Oct. 2016.
79. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1 inhibition subverts TRAIL-mediated osteoclastogenesis.,
第77回日本血液学会学術集会,, Oct. 2016.
80. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, 小田 明日香, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shiroh Fujii, 遠藤 逸郎, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Mechanism of the TRPV1 up-regulatation in myeloma cells and adaptation to an acidic microenvironment.,
第77回日本血液学会学術集会,, Oct. 2016.
81. Keiichiro Watanabe, Jumpei Teramachi, Ryota Amachi, 小田 明日香, Hirofumi Tenshin, 岩浅 正美, Masahiro Hiasa, Shingen Nakamura, 遠藤 逸郎, 川谷 誠, 長田 裕之, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Amelotin gene expression is temporarily being upregulated at the initiation of apoptosis induced by TGFb1 in mouse gingival epithelial cells,
第77回日本血液学会学術集会,, Oct. 2016.
82. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Kiyoe Kurahashi, Takeshi Kondo, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
TAK-1 inhibition disrupts Pim-2-associated and Pim-2-independent key signaling pathways to effectively suppress tumor growth and restore bone formation in myeloma,
第78回 日本血液学会学術集会, Oct. 2016.
83. 高橋 優花, 山下 沙織, Sumiko Yoshida, 桝田 志保, Kana Morimoto, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Tomoyuki Yuasa, Itsuro Endo, Munehide Matsuhisa, Seiji Fukumoto, Hiroyuki Azuma, Masahiro Abe and Ken-ichi Aihara :
生活習慣病患者における血管内皮機能正常群および低下群の臨床指標に関する検討,
第16回日本内分泌学会四国支部学術集会, Sep. 2016.
84. 山上 紘規, Kiyoe Kurahashi, Kana Morimoto, Takeshi Kondo, Itsuro Endo, 明比 祐子, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe :
バセドウ病を合併したTSH産生下垂体腺腫の一例,
第16回日本内分泌学会四国支部学術集会, Sep. 2016.
85. 遠藤 ふうり, Kiyoe Kurahashi, Kana Morimoto, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Akio Kuroda, 明比 祐子, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe :
日和見感染を合併したACTH依存性Cushing症候群の1例,
第253回徳島医学会学術集会(平成28年度夏期), Jul. 2016.
86. Keiichiro Watanabe, Jumpei Teramachi, Ryota Amachi, 小田 明日香, Hirofumi Tenshin, Masahiro Hiasa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, 川谷 誠, 長田 裕之, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
リベロマイシンAによる酸性環境での骨髄腫細胞の治療抵抗性の克服,
日本骨代謝学会学術集会プログラム抄録集 (1349-0761)34回 Page183(2016.07), 183, Jul. 2016.
87. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
破骨細胞はTAK1の発現誘導を介しアポトーシスを抑制しTRAILにより成熟活性化される,
日本骨代謝学会学術集会プログラム抄録集 (1349-0761)34回 Page183(2016.07), 183, Jul. 2016.
88. Kiyoe Kurahashi, Itsuro Endo, Nakamura Mayuko, Ohnishi Yukiyo, Takeshi Kondo, Aizawa Shinichi, Seiji Fukumoto and Masahiro Abe :
カルシウム感知受容体活性型変異による耐糖能異常,
第34回日本骨代謝学会学術総会, Jul. 2016.
89. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Hirofumi Tenshin, Ryota Amachi, 原田 武志, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
骨髄腫腫瘍進展と骨破壊病変形成におけるTAK1-Pim-2経路の役割,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, Jul. 2016.
90. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, 原田 武志, Hirofumi Tenshin, Shingen Nakamura, Ryota Amachi, Shiroh Fujii, Keiichiro Watanabe, Kumiko Kagawa, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Pim-2は骨髄腫における破骨細胞形成促進の 必須媒介因子である,
第41回日本骨髄腫学会学術集会, May 2016.
91. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAILは破骨細胞に細胞死を誘導せず,破骨細胞分化・生存を促進する.,
第41回日本骨髄腫学会, May 2016.
92. 布村 俊幸, Sumiko Yoshida, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa, Toshio Matsumoto and Masahiro Abe :
副腎に接する神経線維腫を合併したレックリングハウゼン病の1例,
第114回日本内科学会四国地方会, May 2016.
93. Kiyoe Kurahashi, 河野 恵理, 宮本 千伸, 津川 和江, Miho Oyadomari, 木村 千寿子, Satoshi Hisanaga, Masatoshi Morimoto, 山川 哲生, 谷内 秀輔, 張 君, Masato Miyake, Masahiro Abe and Seiichi Oyadomari :
ラベルフリー測定によるハイスループットスクリーニングを用いた新規インスリン分泌促進薬の探索,
第59回日本糖尿病学会年次学術集会, May 2016.
94. 橋本 晶慶, 鶴尾 美穂, 秋田 賢子, 森岡 隆子, Akio Kuroda, Tomoyuki Yuasa, Takeshi Kondo, Mizuho Kinouchi, Toshio Matsumoto, Masahiro Abe, Munehide Matsuhisa and 寺澤 敏秀 :
糖尿病教室のスタッフ間の相互評価による改善効果,
第59回日本糖尿病学会年次学術集会, May 2016.
95. Kana Morimoto, Ken-ichi Aihara, Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe :
減塩による2型糖尿病入院症例の 降圧予測指標,
第59回日本糖尿病学会年次学術集会, May 2016.
96. Kana Morimoto, Ken-ichi Aihara, Sumiko Yoshida, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe :
血糖管理入院症例における減塩降圧効果と関連する因子および降圧薬に関する検討,
第5回臨床高血圧フォーラム, May 2016.
97. Kana Morimoto, Ken-ichi Aihara, Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe :
2型糖尿病患者の塩分制限による 降圧効果を規定する因子の検討,
第89回日本内分泌学会学術総会, Apr. 2016.
98. Ken-ichi Aihara, Sumiko Yoshida, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe :
心筋リモデリングおよび頸動脈硬化症 におけるアンジオテンシンII受容体 拮抗薬の効果検証,
第89回日本内分泌学会学術総会, Apr. 2016.
99. 山上 紘規, Kiyoe Kurahashi, 森本 佳奈, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Akio Kuroda, 明比 祐子, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe :
インターフェロンβ治療中に糖尿病ケトアシドーシスを契機とし,急性発症1A型糖尿病と診断された一例,
第252回徳島医学会学術集会 長井記念ホール, Feb. 2016.
100. 森本 佳奈, Ken-ichi Aihara, Sumiko Yoshida, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe :
2型糖尿病患者における血糖指標と減塩がもたらす血圧低下との連関,
第252回徳島医学会学術集会 長井記念ホール, Feb. 2016.
101. 林 亜紀, Takeshi Kondo, Itsuro Endo, Kiyoe Kurahashi, Sumiko Yoshida, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
オクトレオチドLARで画像上,下垂体腺腫が消失した先端巨大症の一例,
第113回日本内科学会四国地方会, Dec. 2015.
102. 森本 佳奈, Takeshi Kondo, Itsuro Endo, 倉橋 清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
著明な低カルシウム血症を来した胃癌の骨転移の一例,
第25回臨床内分泌Update, Nov. 2015.
103. 小山 広士, Takeshi Kondo, 森本 佳奈, Itsuro Endo, 倉橋 清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
ACTH,コルチゾール基礎値正常のACTH単独欠損症の一例,
第25回臨床内分泌Update, Nov. 2015.
104. Takeshi Kondo, Itsuro Endo, 森本 佳奈, 倉橋 清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
テタニーで来院し,Gitelman症候群を疑った一例,
第25回臨床内分泌Update, Nov. 2015.
105. Takayuki Ise, 西條 良仁, Hirokazu Miki, Kumiko Kagawa, 瀬野 弘光, 上野 理絵, 原 知也, 齋藤 友子, Mika Bando, 坂東 左知子, 伊藤 浩敬, Tomomi Matsuura, Koji Yamaguchi, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masahiro Abe and Masataka Sata :
auto-PBSCT とBortezomibの併用が著効した高度心機能障害を伴う原発性心アミロイドーシスの1例,
第107回日本循環器学会四国地方会, Nov. 2015.
106. 花房 剛志, Naoto Okada, 生田 賢治, 小中 健, Kazuyoshi Kawazoe, 中村 敏己, Kazuhiko Teraoka, Masahiro Abe and Keisuke Ishizawa :
自家末梢血幹細胞移植併用大量化学療法施行時の味覚障害に対するクライオセラピーの有用性,
第54回中国四国支部学術大会(高知), Nov. 2015.
107. 花房 剛志, Naoto Okada, 生田 賢治, 小中 健, Kazuyoshi Kawazoe, 中村 敏己, Kazuhiko Teraoka, Masahiro Abe and Keisuke Ishizawa :
自家末梢血幹細胞移植併用大量化学療法施行時の味覚障害に対するクライオセラピーの有用性,
第54回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会,, Nov. 2015.
108. Ken-ichi Aihara, Sumiko Yoshida, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe :
2型糖尿病患者の左室形態 および機能における 強化インスリン療法の効果,
日本糖尿病学会 第53回中国四国地方会, Oct. 2015.
109. 鶴尾 美穂, Akio Kuroda, Takeshi Kondo, Tomoyuki Yuasa, Mizuho Kinouchi, Masahiro Abe, Toshio Matsumoto, Munehide Matsuhisa and 寺澤 敏秀 :
Sensor Angmented Pump(SAP)療法が有効であった高齢1型糖尿病の1例,
第53回日本糖尿病学会中国四国地方会, Oct. 2015.
110. 岡田 祐輝, Takeshi Kondo, 森本 佳奈, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
高CPR血症からグリメピリド誤内服を診断し得た遷延性低血糖の一例,
第53回日本糖尿病学会中国四国地方会 米子コンベンションセンター, Oct. 2015.
111. Ken-ichi Aihara, Sumiko Yoshida, 森本 佳奈, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe :
2型糖尿病患者の左室形態および機能における強化インスリン療法の効果,
第53回日本糖尿病学会中国・四国地方会 米子コンベンションセンター, Oct. 2015.
112. 林 亜紀, Sumiko Yoshida, Akio Kuroda, 七篠 あつ子, Minoru Irahara, 鶴尾 美穂, 森本 佳奈, 倉橋 清衛, Takeshi Kondo, Motoyuki Tamaki, 明比 祐子, Itsuro Endo, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
分娩前に10g/日以上の蛋白尿を合併し,出産に至った糖尿病腎症の1例,
日本糖尿病学会 中国四国地方会第53回総会, Oct. 2015.
113. Satoshi Taniguchi, Akio Kuroda, Motoyuki Tamaki, Hwa In, 森本 佳奈, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe and Munehide Matsuhisa :
CGM iPRO2と人工膵臓STG-55との測定グルコース濃度の比較,
第53回日本糖尿病学会中国・四国地方会 米子コンベンションセンター, Oct. 2015.
114. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, A Oda, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, H Miki, Kumiko Kagawa, Shiroh Fujii, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Mechanism of the TRPV1 up-regulatation in myeloma cells and adaptation to an acidic microenvironment,
第77回日本血液学会学術集会, Oct. 2015.
115. Keiichiro Watanabe, Jumpei Teramachi, H Mori, Y Ochi, Ryota Amachi, A Oda, Masahiro Hiasa, T Harada, Shiroh Fujii, Shingen Nakamura, H Miki, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Potent induction of bone formation by anti-resorptive cathepsin K inhibitor in myeloma,
第77回日本血液学会学術集会, Oct. 2015.
116. 森本 佳奈, Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe :
Significance of glycemic markers for sodium restriction-induced blood pressure reduction in hospitalized patients with type 2 diabetes,
第38日本高血圧学会総会, Oct. 2015.
117. Ken-ichi Aihara, Sumiko Yoshida, 森本 佳奈, 倉橋 清衛, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe :
Evaluation for long-term efficacy of angiotensin II receptor blocker-based antihypertensive therapy on cardiac remodeling and carotid atherosclerosis,
第38日本高血圧学会総会, Oct. 2015.
118. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Potent suppression of osteoclastogenesis in myeloma by Pim inhibition,
第77回日本血液学会学術集会, Oct. 2015.
119. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Tumor reduction and bone restoration in myeloma by TAK-1 inhibition,
第77回日本血液学会学術集会, Oct. 2015.
120. Jumpei Teramachi, Masahiro Hiasa, Hirohiko Okamura, Masahiro Abe and Tatsuji Haneji :
Pim-2を標的とした骨髄腫細胞による骨破壊の抑制,
日本解剖学会第70回中国・四国支部学術集会, Oct. 2015.
121. 森本 佳奈, Takeshi Kondo, Itsuro Endo, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
診断まで長時間を要したACTH分泌低下症の一例,
第15回日本内分泌学会四国支部学術集会 高知大学, Sep. 2015.
122. 加藤 正樹, 森本 佳奈, Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe :
2型糖尿病患者の減塩療法による血圧低下に関連する因子の解析,
第15回 日本内分泌学会 四国支部学術集会, Sep. 2015.
123. 森本 佳奈, Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Masahiro Abe :
2型糖尿病における血糖指標と減塩がもたらす血圧低下との連関,
第251回徳島医学会学術集会 ポスター, Aug. 2015.
124. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Hirofumi Tenshin, Ryota Amachi, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Pim阻害による骨髄種骨病変の治療:破骨細胞形成の抑制,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, Jul. 2015.
125. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Hirofumi Tenshin, Ryota Amachi, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
骨髄腫腫瘍進展と骨破壊病変形成における TAK-1の枢軸的役割,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, Jul. 2015.
126. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAILは破骨細胞分化・生存を促進する:TAK-1による生と死の運命制御,
第1回日本骨免疫学会, 137, Jul. 2015.
127. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, 小田 明日香, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Kumiko Kagawa, Hirokazu Miki, Shiroh Fujii, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
酸環境での骨髄腫細胞のDR4発現抑制:酸によるエピジェネティックな遺伝子発現制御,
第1回日本骨免疫学会, 108, Jul. 2015.
128. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, 小田 明日香, Keiichiro Watanabe, Hirofumi Tenshin, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Takeshi Kondo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
酸性環境での骨髄腫細胞のTRPV1の発現亢進と酸環境への適応,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 165, Jul. 2015.
129. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
アポトーシス誘導因子TRAILによる破骨細胞分化・生存の促進,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 164, Jul. 2015.
130. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, 原田 武志, Ryota Amachi, Hirofumi Tenshin, Hirokazu Miki, Shingen Nakamura, Shiroh Fujii, Kumiko Kagawa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Pim阻害による骨髄腫骨吸収亢進の抑制,
第40回日本骨髄腫学会学術集会, May 2015.
131. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, 原田 武志, Ryota Amachi, Hirofumi Tenshin, Hirokazu Miki, Shingen Nakamura, Shiroh Fujii, Kumiko Kagawa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
TAK-1は骨髄腫腫瘍進展と骨破壊病変形成の枢軸的な媒介因子である,
第40回日本骨髄腫学会学術集会, May 2015.
132. Shingen Nakamura, Hirokazu Miki and Masahiro Abe :
Pim阻害薬と抗骨髄腫治療薬の併用効果の検討,
第40回 日本骨髄腫学会, May 2015.
133. Bingzi Dong, Itsuro Endo, Takeshi Kondo, 大西 幸代, Hiroshi Sakaue, 相澤 慎一, Masahiro Abe and Toshio Matsumoto :
Interleukin-11は脂肪細胞分化を抑制する,
第88回日本内分泌学会, Apr. 2015.
134. Shingen Nakamura, Momoyo Azuma, Hirokazu Miki, Kumiko Kagawa and Masahiro Abe :
当院で経験した重症熱性血小板減少症候群の3例,
第89回 日本感染症学会, Apr. 2015.
135. Naoto Okada, 伏谷 秀治, Momoyo Azuma, 中村 敏己, Kazuhiko Teraoka, Kazuyoshi Kawazoe, Hiroyoshi Watanabe, Masahiro Abe and Keisuke Ishizawa :
病棟薬剤によるプロトコルに基づく薬物治療管理の実践∼抗MRSA薬の適正使用に対する効果∼,
日本薬学会第135年会, Mar. 2015.
136. Naoto Okada, 伏谷 秀治, Momoyo Azuma, 中村 敏己, Kazuhiko Teraoka, Kazuyoshi Kawazoe, Hiroyoshi Watanabe, Masahiro Abe and Keisuke Ishizawa :
病棟薬剤によるプロトコルに基づく薬物治療管理の実践∼抗MRSA薬の適正使用に対する効果,
日本薬学会第135年会(神戸), Mar. 2015.
137. 丸橋 朋子, Shingen Nakamura, 曽我部 公子, 八木 ひかる, 高橋 真美子, 宇高 憲吾, Shiroh Fujii, Hirokazu Miki, Kumiko Kagawa, Masahiro Abe, Atsuro Saijo, Mayuri Nakano, Momoyo Azuma, Yasuhiko Nishioka, 近藤 憲保, 井内 新, 藤田 博己 and 馬原 文彦 :
当院で経験した重症熱性血小板減少症候群の3例,
第250回徳島医学会学術集会, Feb. 2015.
138. Jumpei Teramachi, Masahiro Hiasa, 原田 武志, Ryota Amachi, Kumiko Kagawa, Hirokazu Miki, Shingen Nakamura, Shiroh Fujii, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Therapeutic impact of Pim inhibition on myeloma bone disease: blockade of NF-B-mediated suppression of osteoblastogenesis and stimulation of osteoclastogenesis,
日本血液学会, Oct. 2014.
139. Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Jumpei Teramachi, 小田 明日香, Keiichiro Watanabe, Shingen Nakamura, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
酸が惹起する骨髄腫細胞の酸感受と生存シグナルの悪循環,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 225, Jul. 2014.
140. Dong Bingzi, Itsuro Endo, Takeshi Kondo, 大西 幸代, Masahiro Abe, Seiji Fukumoto, 網塚 憲生, 長谷川 智香, 相澤 慎一 and Toshio Matsumoto :
常染色体優性低Ca血症モデルマウスに対するcalcilyticsの効果,
第32回日本骨代謝学会学術集会, Jul. 2014.
141. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Ryota Amachi, Shingen Nakamura, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Pim-2キナーゼはTNF-αによる骨芽細胞分化抑制および破骨細胞形成促進の必須媒介因子である:Pim阻害薬の骨髄腫骨病変改善効果,
第32回日本骨代謝学会学術集会, Jul. 2014.
142. Itsuro Endo, Masahiro Abe and Toshio Matsumoto :
骨転移に対するdenosumab療法:低Ca血症発現の実態と対策,
第32回日本骨代謝学会, Jul. 2014.
143. Itsuro Endo, Masahiro Abe and Toshio Matsumoto :
骨転移に対するdenosumab療法,
第32回 日本骨代謝学会学術集会, Jul. 2014.
144. Keiichiro Watanabe, Masahiro Abe, H Mori, K Udaka, M Iwasa, D Hanson, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, Shingen Nakamura, H Miki, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka and Toshio Matsumoto :
Bone restoration and tumor suppression in myeloma by cathepsin K inhibition with Bortezomib,
第75回日本血液学会学術集会, Oct. 2013.
145. Ryota Amachi, Keiichiro Watanabe, Masahiro Hiasa, Masahiro Abe, Toshio Matsumoto and Eiji Tanaka :
酸性環境が骨髄腫細胞の破骨細胞活性に及ぼす影響,
第72回日本矯正歯科学会大会プログラム・抄録集, Oct. 2013.
146. Masahiro Abe :
骨髄腫骨病変と腫瘍免疫.シンポジウム5骨免疫と炎症性疾患,
第34回日本炎症・再生医学会, Jul. 2013.
147. 近藤 直樹, 藤田 拓朗, 河上 和代, 野上 浩子, 守時 政宏, 西岡 聡, 西島 陽子, 祖父江 理, 森脇 久美子, 原 大雅, 河野 雅和, 久保 治信, 田中 勉, 渡瀬 謙仁, Akira Mima, 高橋 利和, Toshio Doi, Hirokazu Miki and Masahiro Abe :
免疫抑制療法実施中に赤芽球癆再発した血液透析患者の1例,
第58回日本透析医学会総会, Jun. 2013.
148. Michihiro Nakamura, Koichiro Hayashi, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
有機シリカ・マルチ蛍光ナノプローブによるSeamless蛍光イメーシング,
第8回日本分子イメージング学会学術集会, May 2013.
149. Ryota Amachi, Keiichiro Watanabe, Shiroh Fujii, T Harada, H Miki, S Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
An acdic milieu confers the resistance to TRAIL in myeloma cells through the PI3K-Akt-mediated epigenetic down-regulation of the TRAIL receptor DR4,
International Bone and Mineral Society 2013, May 2013.
150. Keiichiro Watanabe, Masahiro Abe, H Mori, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
Induction of cathepsin K induce bone formation in myeloma osteolytic lesions,
International Bone and Mineral Society 2013, May 2013.
151. Ryota Amachi, Keiichiro Watanabe, Shiroh Fujii, T Harada, H Miki, S Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
An acdic milieu suppresses histone acetylation in myeloma cells to down-regulate the TRAIL receptor DR4 expression,
14th International Myeloma Workshop, Apr. 2013.
152. Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
Induction of bone formation in myeloma osteolytic lesions by cathepsin K inhibition,
14th International Myeloma Workshop, Apr. 2013.
153. Hirokazu Miki, Shingen Nakamura, 竹内 恭子, 原田 武志, 岩佐 昌美, Shiroh Fujii, Kumiko Kagawa, Masahiro Abe and Toshio Matsumoto :
赤芽球癆を合併した多中心性Castleman病の1例,
日本内科学会第107回四国地方会, Dec. 2012.
154. Itsuro Endo, 大薗 卓也, 斉藤 光恵, Toshio Matsumoto and Masahiro Abe :
骨転移に対するdenosumab 120mg皮下注後の重症低Ca血症発現の実態,
癌と骨代謝研究会, Nov. 2012.
155. Motokazu Matsuura, Satoshi Yamada, Eriko Shibata, Kenji Watase, Fumi Kishi, Seiji Kishi, Akira Mima, Kojiro Nagai, Hideharu Abe, Shingen Nakamura, Masahiro Abe and Toshio Doi :
腎生検にてγ重鎖沈着症が疑われた糸球体沈着症の一例,
第42回日本腎臓学会西部学術大会, Oct. 2012.
156. Masahiro Abe :
Multiple myeloma: Topics in basic science applicable to the development of novel therapies,
第74回日本血液学会総会, Oct. 2012.
157. Shiroh Fujii, Masahiro Abe, Ryota Amachi, Keiichiro Watanabe, Masahiro Hiasa, 竹内 恭子, 岩佐 昌美, 原田 武志, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa and Toshio Matsumoto :
Pim inhibition preferentially induces anti-myeloma activity in an acidic milien,
第74回日本血液学会学術集会, Oct. 2012.
158. Masahiro Hiasa, Masahiro Abe, Kumiko Kagawa, Hirokazu Miki, Shingen Nakamura, Harada Takeshi, Fujii Shirou, Keiichiro Watanabe, Ryota Amachi, Kenzo Asaoka and Toshio Matsumoto :
Pim-2 acts as a common downstream mediator to suppress bone formation in myeloma.,
第74回に本血液学会, Oct. 2012.
159. Ryota Amachi, Masahiro Abe, Keiichiro Watanabe, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
An acidic milieu suppresses DR4 editing and induces p22 c-FLIP to cause myeloma resistance to TRAIL,
第74回日本血液学会学術集会, Oct. 2012.
160. 原田 武志, Shuji Ozaki, 岩佐 昌美, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, 柴田 泰伸, 重清 俊雄, 岡田 直人, 長尾 多美子, 鈴木 麗子, Shoji Sakiyama, Masahiro Abe and Toshio Matsumoto :
徳島県のエイズ拠点病院におけるHIV感染症及び後天性免疫不全症候群の現状,
第245回徳島県医学会学術総会, Jul. 2012.
161. Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, Shingen Nakamura, 遠藤 逸郎, 森 裕史, Eiji Tanaka and Toshio Matsumoto :
カテプシンK 阻害剤KK1-300-01 は骨髄腫骨病変部の骨破壊を抑制し骨形成を惹起する,
第30回日本骨代謝学会学術大会, 217, Jul. 2012.
162. Masahiro Hiasa, Masahiro Abe, Rieko Arakaki, Akiko Yamada, Kenzo Asaoka, Toshio Matsumoto, Yoshio Hayashi and Naozumi Ishimaru :
RelB antagonizes the classical NF-κB pathway and its suppression of osteoblastogenesis,
第30回日本骨代謝学会, Jul. 2012.
163. Ryota Amachi, Masahiro Abe, Keiichiro Watanabe, Shingen Nakamura, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
酸性環境は骨髄腫細胞にDR4 の発現抑制とcFLIP の活性化を惹起しTRAIL に対する抵抗性を獲得させる,
第30回日本骨代謝学会学術集会, 259, Jul. 2012.
164. 大黒 由加里, Shingen Nakamura, 岩佐 昌美, 原田 武志, Shiroh Fujii, Kumiko Kagawa, Masahiro Abe, Toshio Matsumoto and Hirokazu Miki :
腰痛と副腎不全症状で発症した両側副腎原発DLBCLの1例,
日本内科学会第106回四国地方会, Jun. 2012.
165. Michihiro Nakamura, Koichiro Hayashi, Aziz Awaad, Hirokazu Miki, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto and Kazunori Ishimura :
有機シリカ粒子技術を用いた近赤外蛍光ナノプローブの作製とユニバーサル蛍光イメージング,
第7回日本分子イメージング学会学術集会, May 2012.
166. 原田 武志, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, 中野 綾子, Kumiko Kagawa, 竹内 恭子, Masahiro Abe and Toshio Matsumoto :
徳島県における多発性骨髄腫の治療成績の検討,
第109回日本内科学会総会・講演会, Apr. 2012.
167. 原田 武志, Shuji Ozaki, 小田 明日香, 天羽 宏枝, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, 中野 綾子, Kumiko Kagawa, 竹内 恭子, Masahiro Abe, 柴田 泰伸 and Toshio Matsumoto :
Lenalidomide 治療中の多発性骨髄腫患者におけるCRP上昇の検討,
第51回日本血液学会中国四国地方会, Mar. 2012.
168. Kumiko Kagawa, 原田 武志, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, 竹内 恭子, Masahiro Abe and Toshio Matsumoto :
遺伝子組み替えヒトトロンボモジュリン投与中に硬膜下血腫を来した同腫骨髄移植2症例,
第34回日本造血細胞移植学会, Feb. 2012.
169. Kumiko Kagawa, 原田 武志, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, 竹内 恭子, Masahiro Abe and Toshio Matsumoto :
遺伝子組み換えヒトトロンボモジュリン投与中に硬膜下血腫を来した同腫骨髄移植2症例,
第34回日本造血細胞移植学会, Feb. 2012.
170. Masahiro Hiasa, Rieko Arakaki, Akiko Yamada, Ritsuko 徳永 律子 Oura, Masahiro Abe, Toshio Matsumoto, Yoshio Hayashi, Naozumi Ishimaru and Kenzo Asaoka :
A novel role of NF-B relB in bone remodeling.,
第40回日本免疫学会学術集会, Nov. 2011.
171. Keiichiro Watanabe, Masahiro Abe, Q Cui, Masahiro Hiasa, M Kawatani, T Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, A Nakano, K Kagawa, K Takeuchi, H Osada, Eiji Tanaka and Toshio Matsumoto :
Targeting an acidic microenvironment by reveromycin A to overcome drug resistance to myeloma cells and ameliorate bone disease.,
第36回日本骨髄腫研究会総会, Nov. 2011.
172. Masahiro Hiasa, Masahiro Abe, 中野 綾子, Kyoko Takeuchi, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Eiji Tanaka, Kenzo Asaoka, Ken-ichiro Yata and Toshio Matsumoto :
Pimキナーゼ阻害による腫瘍進展と骨破壊の抑制,
第73回日本血液学会, Oct. 2011.
173. Takayuki Ise, Takashi Iwase, Kumiko Kagawa, Toshiyuki Niki, Kenya Kusunose, 冨田 紀子, Yuka Ueda, Koji Yamaguchi, Yoshio Taketani, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masahiro Abe, Masashi Akaike and Masataka Sata :
Successful Autologous Peripheral Blood Stem Cell Transplantation for Primary Cardiac Amyloidosis Patients with Heart Failure : three cases report.,
第15回 日本心不全学会学術集会, Oct. 2011.
174. Masahiro Hiasa, A Nakano, Keiichiro Watanabe, C Qu, T Harada, S Fujii, H Miki, S Nakamura, K Kagawa, K Takeuchi, Eiji Tanaka, Kenzo Asaoka, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition,
Bone Biology Forum, 19-21st Aug, 2011, Shizuoka., Aug. 2011.
175. Keisuke Fujioka, Atsuro Saijo, Yuko Toyoda, Souji Kakiuchi, Masaki Hanibuchi, Masahiko Azuma, Yasuhiko Nishioka, Kyoko Takeuchi, Shiroh Fujii, Shingen Nakamura, Kumiko Kagawa, Masahiro Abe and Tomoya Mizutani :
不明熱で発症し皮膚生検が診断に有効であった血管内リンパ腫の1例,
第243回徳島医学会学術集会, Jul. 2011.
176. Masahiro Hiasa, Masahiro Abe, 中野 綾子, Keiichiro Watanabe, Shingen Nakamura, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する,
第29回日本骨代謝学会学術大会, 178, Jul. 2011.
177. Keiichiro Watanabe, Masahiro Abe, 川谷 誠, Masahiro Hiasa, Shingen Nakamura, Eiji Tanaka, 長田 裕之 and Toshio Matsumoto :
リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の抑制,
第29回日本骨代謝学会学術大会, 208, Jul. 2011.
178. Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
Reveromycin A prevents bone destruction and suppresses tumor growth in myeloma,
第72回日本血液学会, Dec. 2010.
179. 宇高 憲吾, Naoko Matsui, 宮本 亮介, Yuka Terasawa, Kenta Sato, Koutaro Asanuma, Yuishin Izumi, Ryuji Kaji, Shiroh Fujii, Kyoko Takeuchi, Masahiro Abe and Masafumi Harada :
多発性骨髄腫の経過中に進行性多巣性白質脳症をきたした一例,
Shikoku Acta Medica, Vol.66, No.5-6, 198, Dec. 2010.
180. Kumiko Kagawa, Jinno Tasashi, Harada Kakeshi, Cui Qu, Keiichiro Watanabe, Masahiro Hiasa, Oda Asuka, Amo Hiroe, Akishige Ikegame, Miki Hirokazu, Shiroh Fujii, Nakano Ayako, Kyoko Takeuchi, Shuji Ozaki, Masahiro Abe and Toshio Matsumoto :
Sensitization of hematopietic malignant cells to TRAIL with bortezomib and a TACE inhibitor,
第72回日本血液学会, Sep. 2010.
181. Shingen Nakamura, Masahiro Abe, Cui Qu, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, Miki Hirokazu, Nakano Ayako, Oda Asuka, Amo Hiroe, Jinno Tasashi, Harada Takeshi, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
Bortezomib-induced osteoblast differentiation is hampered by excessive ER stress,
第72回日本血液学会, Sep. 2010.
182. Masahiro Hiasa, Masahiro Abe, 中野 綾子, 小田 明日香, 天羽 宏枝, Kyoko Takeuchi, Kumiko Kagawa, Shingen Nakamura, 三木 浩和, Ken-ichiro Yata, Keiichiro Watanabe, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka and Toshio Matsumoto :
Bone marrow stromal cells supress TACE activity in monocytes to induce osteoclastogenesis,
第72回日本血液学会, Sep. 2010.
183. Cui Qu, Masahiro Abe, Miki Hirokazu, Shingen Nakamura, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, Nakano Ayako, Jinnno Tadashi, Harada Takeshi, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
Bone marrow stromal cells attenuate gama delta T,
第72回日本血液学会, Sep. 2010.
184. Masahiro Hiasa, Masahiro Abe, Toshio Matsumoto and Kenzo Asaoka :
骨髄間質細胞は単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞分化を誘導する,
第3回ナノ・バイオメディカル学会大会, Sep. 2010.
185. Masahiro Hiasa, Masahiro Abe, 中野 綾子, 小田 明日香, 天羽 宏枝, Kyoko Takeuchi, Kumiko Kagawa, Shingen Nakamura, 三木 浩和, Ken-ichiro Yata, Keiichiro Watanabe, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka and Toshio Matsumoto :
骨髄間質細胞は,単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞文化を誘導する,
第28回日本骨代謝学会, Jul. 2010.
186. Keiichiro Watanabe, Masahiro Abe, Kawatani Makoto, Masahiro Hiasa, Shingen Nakamura, Eiji Tanaka, 長田 裕之 and Toshio Matsumoto :
リベロマイシンAは骨髄腫骨破壊病変の形成と腫瘍進展を抑制する,
第28回日本骨代謝学会, Jul. 2010.
187. Shingen Nakamura, Masahiro Abe, Cui Qu, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, 三木 浩和, 中野 綾子, 小田 明日香, 天羽 宏枝, 神野 雅, 原田 武志, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
ボルテゾミブによる骨芽細胞分化の促進は過剰な小胞体ストレスによって抑制される,
第28回日本骨代謝学会, Jul. 2010.
188. Daisuke Tsuji, Shuji Ozaki, Akishige Ikegame, 伊藤 良和, 徳田 美幸, 岡野 和真, Masahiro Abe, Toshio Matsumoto and Kouji Itou :
ヒト多発性骨髄腫由来ガン幹細胞の単離及び性質決定,
第82回日本生化学会大会, Oct. 2009.
189. Itsuro Endo, 大西 幸代, 木戸 里佳, 倉橋 清衛, Sumiko Yoshida, Yuichi Fujinaka, Ken-ichi Aihara, Masahiro Abe, 福本 誠二 and Toshio Matsumoto :
新規calcilytics,JTT305は常染色体優性低Ca血症におけるCa感知受容体活性型変異シグナルを抑制する,
第27回日本骨代謝学会学術集会, 195, Jul. 2009.
190. Kumiko Kagawa, Ken-ichiro Yata, 田中 修, Shingen Nakamura, Hirokazu Miki, Kyoko Takeuchi, Masahiro Abe, Shuji Ozaki, Sumiko Yoshida and Itsuro Endo :
心筋への広範な直接浸潤を来したNK/T cell lymphoma 鼻型の一例,
第48回に本血液学会中国四国地方会, Mar. 2009.
191. Masahiro Hiasa, Masahiro Abe, 竹内 恭子, Ken-ichiro Yata, Kumiko Kagawa, 三木 浩和, Shuji Ozaki, Kenzo Asaoka and Toshio Matsumoto :
骨髄間質細胞は単球のM-CSFR発現を増強し単球由来樹状細胞分化を抑制し骨髄腫細胞による破骨細胞分化を促進する,
日本骨代謝学会 ・学術総会, Oct. 2008.
192. 竹内 恭子, Masahiro Abe, Masahiro Hiasa, 田中 修, 中村 信元, 三木 浩和, Kumiko Kagawa, Ken-ichiro Yata, Shuji Ozaki and Toshio Matsumoto :
骨髄腫骨病変部由来TGF-βは,脂肪細胞分化を抑制し骨髄内に間質細胞を誘導する,
日本骨代謝学会 ・学術総会, Oct. 2008.
193. 竹内 恭子, Masahiro Abe, Masahiro Hiasa, 田中 修, 中村 信元, 三木 浩和, Kumiko Kagawa, Ken-ichiro Yata, Shuji Ozaki and Toshio Matsumoto :
TGF-βによる間質細胞からの脂肪細胞分化の抑制,
日本血液学会, Oct. 2008.
194. Ken-ichiro Yata, Masahiro Abe, Masahiro Hiasa, 竹内 恭子, 田中 修, 中村 信元, 三木 浩和, Kumiko Kagawa, Shuji Ozaki and Toshio Matsumoto :
骨髄腫細胞と間質細胞の共存は単球M-CSFR発現増強を介し単球分化を破骨細胞側に偏らせる,
日本血液学会, Oct. 2008.
195. Masahiro Hiasa, Masahiro Abe, Kenzo Asaoka and Toshio Matsumoto :
inhibition of osteoclastgenesis by ectodomain shedding of M-CSF receptor,
17, Aug. 2008.
196. Takashi Iwase, 住友 由佳, Shusuke Yagi, Yasumasa Ikeda, Ken-ichi Aihara, Shuji Ozaki, Masashi Akaike, Masahiro Abe, Toshio Matsumoto and Tetsuya Kitagawa :
エリスロポイエチンを用いた新たな血管新生療法の試み,
第104回日本内科学会総会・講演会, Vol.96, No.Suppl., 133, Apr. 2007.
197. 宮本 貴子, 木戸 慎介, Masahiro Abe, Toshio Matsumoto and Hisaaki Taniguchi :
Differential Proteomicsによる骨芽細胞分化の解析,
第24回日本骨代謝学会, Jul. 2006.
198. Atsushi Shioyasono, Yasuo Oba, Hiasa Masahiro, Masahiro Abe, Toshio Matsumoto and Keiji Moriyama :
Expression of chemokines in the periodontal tissue during tooth movement,
第64回 日本矯正歯科学会大会, Oct. 2005.
199. 田中 洋一, Masahiro Abe, Masahiro Hiasa, Toshihiro Hashimoto, Shinsuke Kido, Daisuke Inoue, Shuji Ozaki, Keiji Moriyama and Toshio Matsumoto :
骨髄腫細胞,破骨細胞と血管内皮細胞の細胞間相互作用:腫瘍進展,骨破壊と血管新生の促進,
第23回日本骨代謝学会学術集会, Jul. 2005.
200. 田中 洋一, Masahiro Abe, 日浅 雅博, Toshihiro Hashimoto, 木戸 慎介, Daisuke Inoue, Shuji Ozaki, Keiji Moriyama and Toshio Matsumoto :
骨髄腫細胞,破骨細胞と血管内皮細胞の細胞間相互作用:腫瘍進展,骨破壊と血管新生の促進,
第23回日本骨代謝学会学術集会, Jul. 2005.

Et cetera, Workshop:

1. 安井 沙耶, 桝田 志保, Sumiko Yoshida, 辻本 賀美, 工藤 千晶, 遠藤 ふうり, 三井 由加里, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto :
成長ホルモン分泌不全症と甲状腺機能低下症を呈した小児がん経験者の一例,
第259回 徳島医学会学術集会(令和元年度夏期), Aug. 2019.
2. Jumpei Teramachi, Hirofumi Tenshin, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
骨髄腫特異的抗腫瘍活性と骨再生をもたらす新規分子標的薬の開発,
2018 先端医学交流セミナー, Aug. 2018.
3. Jumpei Teramachi, Masahiro Hiasa and Masahiro Abe :
Development of novel anti-myeloma agents with potent bone anabolic actions,
14th Bone Biology Forum, Aug. 2017.
4. Masahiro Hiasa, T Okui, Masahiro Abe and T Yoneda :
Targeting the myeloma-induced acidic microenvironment decreases bone pain,
第78回日本血液学会学術集会, Oct. 2016.
5. Itsuro Endo, Kumiko Kagawa, Hirokazu Miki, 高橋 真美子 and Masahiro Abe :
B細胞リンパ腫を合併した先端巨大症の一例,
第3回四国GH/IGF1フォーラム, Feb. 2014.
6. Ryota Amachi, Masahiro Abe, Keiichiro Watanabe, Kumiko Kagawa, Shiroh Fujii, 原田 武志, Hirokazu Miki, Keiichiro Watanabe, 小野 明日香, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
骨髄腫の酸性環境はTRAIL受容体発現をエピジェネティックに抑制し,TRAIL抵抗性をもたらす,
第20回徳島骨代謝研究会, Nov. 2013.
7. Dong Bingzi, Itsuro Endo, Takeshi Kondo, Yukiyo Ohnishi, Masahiro Abe, Shin-ichi Yoshizawa, Seiji Fukumoto and Toshio Matsumoto :
The Effect of calcilytics on activating mutation of calcium-sensing repceptor knock-in mice model of autosomal dominant hypocalcemia,
骨とCaクラスターミニリトリート, Feb. 2013.
8. Itsuro Endo, 大薗 卓也, 齋藤 光恵, 久保田 由紀子, Masahiro Abe and Toshio Matsumoto :
骨転移に対するdenosumab 120mg 皮下注後の重傷低Ca血症発現の実態,
第15回癌と骨病変研究会, Nov. 2012.
9. Keiichiro Watanabe, Masahiro Abe and Toshio Matsumoto :
リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の制御,
第15回癌と骨病変研究会, Nov. 2012.
10. Ryota Amachi, Masahiro Abe, Keiichiro Watanabe, Kumiko Kagawa, 藤井 志郎, 原田 武志, Hirokazu Miki, Shingen Nakamura, 小田 明日香, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
酸環境は骨髄腫細胞のTRAILに対する抵抗性を増強する,
第3回骨バイオサイエンス研究会, Jul. 2012.
11. Masahiro Hiasa, Masahiro Abe, 中野 綾子, Keiichiro Watanabe, Kyoko Takeuchi, Kumiko Kagawa, Hirokazu Miki, Shingen Nakamura, Shiroh Fujii, 原田 武志, Shuji Ozaki, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Pimキナーゼの阻害による骨髄腫の進展抑制,
癌と骨病変研究会, Nov. 2011.
12. Keiichiro Watanabe, Masahiro Abe, 崔 衢, 川谷 誠, Masahiro Hiasa, 長田 裕之, Eiji Tanaka and Toshio Matsumoto :
A novel anti-resorptive agent, reveromycin A, ameliorates bone destruction and tumor growth in myeloma,
第2回骨バイオサイエンス研究会, Jul. 2011.
13. Masahiro Hiasa, Masahiro Abe, 中野 綾子, 小田 明日香, 天羽 宏枝, Kyoko Takeuchi, Kumiko Kagawa, Shingen Nakamura, 三木 浩和, Ken-ichiro Yata, Keiichiro Watanabe, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka and Toshio Matsumoto :
骨髄間質細胞は,単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞文化を誘導する,
第17回徳島骨代謝研究会, Nov. 2010.
14. Keiichiro Watanabe, Masahiro Abe, 崔 衢, 川谷 誠, 長田 裕之, Eiji Tanaka and Toshio Matsumoto :
リベロマイシンAの骨髄腫骨病変と腫瘍進展抑制作用,
第1回骨バイオサイエンス研究会, Jun. 2010.
15. Itsuro Endo, 大西 幸代, 木戸 里佳, 倉橋 清衛, Yuichi Fujinaka, Ken-ichi Aihara, Sumiko Yoshida, Masahiro Abe, Seiji Fukumoto and Toshio Matsumoto :
Ca感知受容体機能に及ぼすcalcilyticsの作用,
第3回瀬戸内フォーラム, Aug. 2009.
16. Ken-ichiro Yata, Masahiro Abe, 竹内 恭子, Masahiro Hiasa, 中野 綾子, 三木 浩和, 田中 修, 中村 信元, Kumiko Kagawa, Shuji Ozaki and Toshio Matsumoto :
骨髄間質細胞はγδT細胞による抗骨髄腫効果を減弱させる,
日本骨髄腫研究会総会, Nov. 2008.

Patent:

1. Atsushi Nakayama, Jumpei Teramachi, Masahiro Abe, Kosuke Namba, Kouji Itou and Daisuke Tsuji : 新規イノン化合物及びその用途, (Oct. 2018), 2018-203219 (Oct. 2018).

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

  • TAK1-Pim-2経路がもたらす骨髄腫の難治性と骨破壊の役割とその克服法の開発 (Project/Area Number: 18K08329 )
  • Cancer Diagnosis and Prognosis Assistance Based on Multidisciplinary Computational Anatomy (Project/Area Number: 26108007 )
  • Mechanisms of myeloma growth in bone marrow microenvironment and development of novel therapeutic options for myeloma (Project/Area Number: 26461422 )
  • Elucidation of molecular mechanism of the regulation of skeletal homeostasis, and development of new therapeutic approaches against skeletal disorders (Project/Area Number: 25293215 )
  • Mechanisms of bone destruction and drug resistance in myeloma: a novel therapeutic strategy targeting a myeloma-bone marrow interaction (Project/Area Number: 23591390 )
  • Computer-Aided Diagnosis Based on Computational Anatomical Models (Project/Area Number: 21103005 )
  • Relationships among skeletal, adipose and vasclar regulatory system, and elucidation of pathogensis caused by disturbances of these systems (Project/Area Number: 20249050 )
  • Molecular mechanic sum of the regulation and dies regulation of bone homeostasis and Development of therapeutic approaches (Project/Area Number: 17209035 )
  • Identification and clinical application of osteoclast-derived growth factors for myeloma (Project/Area Number: 15591010 )
  • Elucidation of signal transduction pathway via HM1.24 and application toward the treatment of hematological malignancies (Project/Area Number: 14570984 )
  • Roles for MIP-1α and β in the development of osteolytic lesions in multiple myeloma (Project/Area Number: 13671067 )
  • Development of immunotherapy targeting neoplastic lymphocyte-specific antigen (2D7) against hematological malignancies (Project/Area Number: 13557082 )
  • 骨格系の制御に関わる転写因子と骨粗鬆症におけるその異常 (Project/Area Number: 12137207 )
  • Mechanism of signal transduction that regulates osteoclast differentiation and its abnormalities in bone distructive diseases (Project/Area Number: 11470227 )
  • Search by Researcher Number (80263812)